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Abstract   
Expression of mutant M.EcoRII protein (M.EcoRII-C186A) in Escherichia coli 
leads to tightly bound DNA-protein complexes (TBCs), located sporadically on the 
chromosome rather than in tandem arrays. The mechanisms behind the lethality induced 
by such sporadic TBCs are not well studied, nor is it clear whether very tight binding but 
non-covalent complexes are processed in the same way as covalent DNA-protein 
crosslinks (DPCs). Using 2D gel electrophoresis, we found that TBCs induced by 
M.EcoRII-C186A block replication forks in vivo. Specific bubble molecules were detected 
as spots on a 2D gel, only when M.EcoRII-C186A was induced, and a mutation that 
eliminates a specific EcoRII methylation site led to disappearance of the corresponding 
spot. We also performed a candidate gene screen for mutants that are hypersensitive to 
TBCs induced by M.EcoRII-C186A. We found several gene products necessary for 
protection against these TBCs that are known to also protect against DPCs induced with 
wild-type M.EcoRII (after aza-C incorporation): RecA, RecBC, RecG, RuvABC, UvrD, 
FtsK, and SsrA (tmRNA). In contrast, the RecFOR pathway and Rep helicase are 
needed for protection against TBCs but not DPCs induced by M.EcoRII. We propose 
that stalled fork protection by RecFOR and RecA promotes release of tightly bound (but 
non-covalent) blocking proteins, perhaps by inducing Rep helicase-driven dissociation of 
the blocking M.EcoRII-C186A. Our studies also argued against the involvement of 
several proteins that might be expected to protect against TBCs.  
We took the opportunity to directly compare the sensitivity of all tested mutants to 
two quinolone antibiotics, which target bacterial type II topoisomerases and induce a 
unique form of DPC. We uncovered rep and ftsK as novel quinolone hypersensitive 
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mutants, and also obtained evidence against the involvement of a number of functions 
that might be expected to protect against quinolones. Other work with quinolones 
showed a mild reduction in the SOS response to DNA damage by quinolones in recQ 
mutants. We also determined that the quinolone resistance seen in an icdA mutant is not 
due to the up-regulation of the AcrAB-TolC efflux pump.  
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Chapter 1:  Background   
1.1 Prokaryotic model systems for studying genome instability 
relevant to cancer 
Escherichia coli is a valuable system for studying DNA damage, because DNA 
replication, repair, and protection mechanisms are highly conserved from bacteria to 
humans. Bacteria are also exposed to most of the same DNA damaging agents as 
eukaryotes, have similar protective mechanisms, a short generation time and are easily 
manipulated, making E. coli a great model system.  
A relationship between cancer and genomic instability has been well established 
[1]. One of the best examples of the value of using a prokaryotic system to understand 
DNA repair and carcinogenesis in humans is mismatch repair (MMR), which was first 
discovered in E. coli from a study of mutants with an elevated mutation frequency (for 
review, [2]). Mutations in the E. coli genes mutS, mutL, mutH, uvrD and dam [3,4,5,6] 
lead to an elevated mutation rate. These genes were determined to be involved in the 
post replicational repair of DNA mismatches referred to as the mismatch repair system. 
A similar mismatch repair system was found in humans [7]. Mutations in the human 
homologs of MutS and MutL result in susceptibility to hereditary non-polyposis colorectal 
cancer (HNPCC), one of the most common cancer predisposition diseases in humans 
(for review, [8]).  
Three other genes in E. coli found to yield a high mutation frequency when 
disrupted are mutM, mutY, and mutT [9]. Studying these genes uncovered how bacteria 
and human cells repair damage caused by 8-oxoG, created by oxidative damage to a 
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guanine residue. 8-oxoG is highly mutagenic because it can pair with adenine as well as 
cytosine, leading to G:C  T:A transversions. MutM removes 8-oxoG residues opposite 
cytosine residues [10,11] and MutY removes adenine residues across from 8-oxoG [9], 
allowing for proper pairing with cytosine. Mutations in the corresponding human proteins 
OGG1 and MYH, respectively, can lead to a susceptibility to colon cancer [12]. MutT, the 
first mutator mutant described in E. coli [13], removes 8-oxoG from the nucleotide pool 
[14] and has a corresponding human protein, MTH, which performs the same function.  
Alkylating mutagens can damage guanine by attaching a methyl group to the 
oxygen atom, leading to mispairing with thymine rather than cytidine. The repair of O6-
methylguanine was defined in E. coli mutants defective for two DNA repair 
methyltransferases [15]. These mutants were found to have a high rate of spontaneous 
mutation, suggesting they were deficient in a DNA repair or protection mechanism and 
were therefore studied further. The study of these mutants uncovered the mechanisms 
for repairing O6-methylguanine lesions. Eukaryotic cells are also subject to O6-
methylguanine lesions and repair the lesions in a similar manner as prokaryotes [16]. 
1.2 SOS response to DNA damage 
The SOS response in E. coli is a physiological response to DNA damage that 
involves the regulation of 20-40 genes. The mechanisms for the regulation of the SOS 
response are well understood (for reviews, see [17,18,19,20]). The genes regulated by 
the SOS response encode proteins involved in DNA repair, cell-cycle inhibition, and 
SOS-induced mutagenesis. The expression of genes involved in the SOS response is 
controlled by RecA and LexA. In uninduced cells, LexA binds to operator sequences 
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upstream of each SOS gene, repressing transcription. The SOS response is induced 
when RecA binds regions of single-stranded DNA, created by DNA damage or during 
the process of repairing the damage. RecA then undergoes a conformational change 
that leads to activation of its coprotease activity, and then RecA promotes the 
autocleavage of LexA. Cleavage of LexA removes repression from SOS genes and 
leads to induction of these genes. When exposed to quinolone antibiotics, the SOS 
response is induced through the double-strand break (DSB) processing RecBCD 
pathway [21]. Mitomycin-C (MMC) and UV also induce the SOS response, but do so 
through the RecFOR pathway, presumably because MMC and UV damage lead to 
single stranded DNA (ssDNA) and blocked forks rather than DSBs [21]. 
1.3 Introduction to E. coli HR pathways  
Homologous recombination (HR) is a method to repair damaged DNA by 
exchanging nucleotide sequences between two DNA molecules. RecA, which catalyzes 
the strand exchange reaction, is the crucial protein in all HR reaction. RecBCD assists 
RecA to repair DSB damage via HR (Figure 1; for reviews, see [22,23,24]). DNA 
damage, such as a fork blocked by a TBC, can lead to a broken replication fork. 
Homologous recombination can restart a broken replication fork, which requires both 
RecA and RecBCD. RecBCD helicase/exonuclease binds to a double-stranded DNA 
end and unwinds the 5’  DNA end until it reaches the Chi sequence (5’ GCTGGTGG 3’) 
and nicks the 3’ end. This produces the ssDNA substrate of a 3’ overhang for RecA to 
bind. RecBCD loads RecA onto the DNA. RecA performs strand invasion with a 
homologous region of DNA. Stand invasion produces a D-loop which serves as a site for 
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PriA to initiate assembly of the replisome. The recombination reaction yields a Holliday 
junction, which is resolved by either the RuvABC resolvasome or branch migration by 
RecG helicase [25,26,27].  
The RecFOR pathway is another pathway that assists in RecA-mediated 
recombination, but the RecFOR pathway processes single-stranded gaps rather than 
DNA ends (Figure 2; [28,29]). A gap in the DNA can arise when a damaged DNA 
template is replicated. RecJ exonuclease binds to the 5' end of a single-strand gap in 
DNA and along with RecQ helicase, moves along the DNA cleaving the 5' strand 
creating a 3’ overhang [30]. RecFOR loads RecA onto the 3’ overhang [31] allowing 
RecA to catalyze HR. RecA performs strand invasion with a homologous region. This 
forms a Holliday junction which can be branch migrated by RuvABC and possibly RecG. 
The Holliday junction is resolved by RuvABC. 
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Figure 1:  RecBCD assisted RecA-homologous recombination 
This pathway involves the response of a fork that is blocked by a TBC. Parental 
DNA is black, the nascent strand is orange. TBC: tightly bound DNA-protein complex, A: 
RecA, BCD: RecBCD, PriA: PriA, G: RecG, ABC:  RuvABC. 
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Figure 2:  RecFOR assisted RecA-homologous recombination model for 
daughter strand gap repair 
This pathway involves DNA damage that leads to a gap. Parental DNA is black, 
the nascent strand is orange. Star:  template damage, A: RecA, FOR: RecFOR, G: 
RecG, ABC:  RuvABC. 
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1.4 Replication fork blockage and restart pathways 
When the DNA replication machinery encounters DNA damage of various kinds, 
or unusual situations such as secondary structures, DNA crosslinks and tightly bound 
proteins, replication fork blockage can occur (for reviews, see [32,33]). Blocked 
replication forks in turn can induce DNA damage responses, and can also lead to 
mutation or cell death. Recent work has begun to unravel multiple pathways that cells 
use to restore active replication after fork blockage; some of these involve damage 
repair while others simply avoid the damage, leaving it in one of the daughter duplexes 
(for reviews, see [34,35,36]).  
1.4.1 Replication fork direct restart 
Direct restart can reactivate a stalled replication fork, if the fork block is quickly 
removed. Direct restart requires PriA, a component of the primosome. The primosome is 
a six-protein complex that begins assembly with PriA binding to DNA. Binding of PriB, 
PriC and DnaT follows. Then DnaC loads DnaB, the replicative DNA helicase. DnaG 
associates and synthesizes the RNA primer [37,38]. When the block is cleared and the 
replicative helicase is reloaded, replication can resume. Direct fork restart can also occur 
from D-loops formed during recombination. 
1.4.2 Fork regression pathway for replication fork restart 
If the fork block is not quickly removed, fork regression may be necessary for 
repair (for review, see [39]). If the lesion is not in duplex DNA, fork regression can move 
it back into a duplex region, allowing for repair from a conventional pathway, such as 
NER (Figure 3). Another model is strand-switch synthesis, which also starts with fork 
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regression (Figure 3). Then a lesion in the leading-strand can be bypassed by using the 
lagging-strand product as a template [40]. The lesion can be repaired before subsequent 
rounds of replication. 
1.4.3 Recombination dependent replication fork restart 
Homologous recombination can restart a broken replication fork. RecA and 
RecBCD are crucial for this pathway. The steps are described in Section 1.3 and Figure 
1. 
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Figure 3: Models of replication fork restart 
These pathways involve the response of a fork that is stalled by leading-strand 
damage; some of these pathways are also relevant for lagging-strand damage. Various 
steps are indicated by arrows; the color of the arrow corresponds to the color of the text 
describing a particular step. Parental DNA is black, the nascent leading strand is solid 
red, and the nascent lagging strand is dashed red. Template DNA damage is indicated 
by the small black boxes, and the short segment of DNA from strand switch synthesis is 
blue (from reference [39]). 
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1.5 Systems that create deleterious DNA-protein complexes 
1.5.1 Aza-C-induced M.EcoRII DNA-Protein crosslinks  
DNA-protein crosslinks (DPCs) are particularly difficult to study, therefore poorly 
understood form of damage that creates blocked replication forks [41,42,43]. A 
challenge in studying DPCs is that many inducing agents, such as radiation and 
formaldehyde, create DPCs throughout the chromosomal DNA and the crosslinks 
involve a wide variety of different DNA-binding proteins [41,42]. A number of DNA 
damaging agents, including ultraviolet light (UV), ionizing radiation, formaldehyde, 
certain carcinogens, and some chemotherapeutic drugs, cause proteins to become 
trapped on DNA in DPCs, which have been shown to block DNA replication.  
One system used to avoid the challenges of studying DPCs that are formed with 
a variety of proteins across the chromosome utilizes the chemotherapeutic drug 
Azacytidine (aza-C). Aza-C leads to DPCs that are both DNA site-specific and protein-
specific. Aza-C is a cytidine analog in which the carbon-5 (C5) of the pyrimidine ring is 
replaced with nitrogen. M.EcoRII acts on this particular cytosine residue within the 
EcoRII recognition sequence by transferring the methyl group from S-
adenosylmethionine to C5 [44]. However, when the cytidine analog Aza-C is 
incorporated into the target sequence, an irreversible and covalent DPC is formed 
between M.EcoRII and its DNA recognition sequence (5’-CCWGG). Several groups 
have used aza-C-induced M.EcoRII DPCs as a model system to investigate how cells 
respond to and repair DPCs  ([28,43,45,46,47,48,49]; reviewed in [42]; Krasich et al., 
unpublished data).  
  
 
11
Previous work from our lab used 2D agarose gel electrophoresis to visualize the 
accumulation of replication forks blocked at aza-C-induced DPCs [43]. Sensitivity of 
mutants to aza-C-induced DPCs has been studied in our lab and others and results are 
summarized in Chapter 4, Table 4. Mutants of recA ([45,46,47,48]; Krasich et al., 
unpublished data) and recC ([48]; Krasich et al., unpublished data) are hypersensitive to 
aza-C-induced DPCs, arguing that DSBs are formed. RecBCD and RecA may play a 
direct role in repairing DPCs, or may be involved in repairing downstream DNA damage 
such as broken replication forks. 
 As mentioned above, to restart replication after the formation of DSBs, RecBCD 
assists in RecA-mediated recombination which generates Holliday junctions that can be 
resolved by RuvABC. Mutations in ruvABC also cause hypersensitivity to aza-C ([48]; 
Krasich et al., unpublished data). Helicases UvrD  [48,49] and DinG (Krasich et al., 
unpublished data) may play a special role in DPC repair, as mutations in both lead to 
hypersensitivity to aza-C-induced DPCs. An interesting finding in our lab is that ssrA 
mutants are hypersensitive to aza-C-induced DPCs, arguing that tmRNA plays an 
important role in clearing stalled ribosome-mRNA complexes generated after 
transcription is blocked by aza-C-induced DPCs [49]. 
1.5.2 DPCs with topoisomerase 
In E. coli, quinolone antibiotics target topoisomerase IV [50] and topoisomerase II 
(gyrase) [51,52] and stabilize a unique form of DPC called the cleavage complex. 
Quinolone-stabilized DNA gyrase cleavage complexes block replication forks in vivo 
[53]. In eukaryotes, the chemotherapeutic drugs, including doxorubicin and etoposide, 
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target topoisomerase II and also stabilize the cleavage complex. This topic is discussed 
further in Chapter 3. 
1.5.3 Tandem repressor-operator complexes 
Replication can also be blocked by tightly bound but non-covalent complexes 
[54,55], and it is not clear whether the processing and consequences of TBCs are similar 
to those of DPCs. One system that has been used to study the consequences of 
replication fork blocks created by TBCs involves tandem repressor-operator complexes. 
E. coli strains expressing either TetR or LacI repressor, with tandem arrays of 240 
copies of the respective binding sites (tetO or lacO) in the chromosome, demonstrated 
site-specific and reversible blockage of chromosomal replication at the TBC array [55]. 
Replication appeared to sometimes proceed a short distance into the array, suggesting 
some limited success at replication through the blockage. When the TBCs were present 
for 2 hours and then reversed by addition of the appropriate inducer, replication was 
shown to rapidly restart in either wild-type or recA mutant cells [55]. However, 
maintaining the chromosomal TBC array for 4 hours in wild-type cells led to a massive 
loss of viability, and so eventually some toxic event is induced by the long TBC arrays 
[55].  
Shorter TBC arrays (22 or 34 copies) were also found to create replication fork 
blockage in vivo, and arrays even shorter than that blocked replication in vitro but not in 
vivo [56]. These results suggested that factors, such as recombination proteins and/or 
helicases, can prevent or ameliorate fork blockage in vivo. Interestingly, RecA, RecBCD, 
and RecG were all required for cell viability in the presence of the 34-copy TBC arrays, 
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whereas RecF, Rep, UvrD, and RuvABC were not [56]. These genetic results imply that 
DSBs are somehow formed in response to the replication blocks. While rep and uvrD 
single mutants were viable with the 34-copy TBC arrays, a later study revealed a 
synthetic phenotype indicating redundant roles of Rep and UvrD in promoting replication 
through the 34-copy TBC array [57]. 
1.5.4 Solo, non-arrayed TBCs 
Tandem arrays of TBCs present a rather unnatural obstacle to DNA replication, 
and their processing and consequences might be distinct from single TBCs. Two 
different tight binding proteins, active site (catalytically inactive) mutants of a restriction 
nuclease and a restriction methyltransferase, have been used to generate solo, 
sporadically located (non-arrayed), TBCs. The E111G mutant of EcoRI nuclease binds 
very tightly to its recognition sequence and causes lethality when expressed at high 
levels [58], as does the C186A mutant of M.EcoRII [59,60,61]. M.EcoRII-C186A induced 
TBCs are the subject of Chapter 2 and will be discussed in greater detail. The E111G 
EcoRI protein blocks E. coli replication forks in vitro, and either Rep or UvrD helicase 
(but not RecG, PriA or Mfd) can relieve the replication block [57]. TBCs created with a 
mutant EcoRI nuclease were also shown to block transcription in vitro [62], although a 
later study showed that additional trailing RNA polymerases can allow the transcription 
complex to push through the TBC, dislodging the protein in the process [63]. These 
studies show that solo TBCs are potent replication and transcription blocks in vitro, and 
that they can be cytotoxic in vivo. However, they do not illuminate the in vivo molecular 
consequences nor the pathways that cells might use to overcome solo TBCs. The 
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studies with both tandem and solo TBCs also support an important redundancy in which 
Rep and UvrD generally assist the replication fork in overcoming protein blockage of 
various types. 
1.5.5 Collisions with RNA polymerase  
Several studies argue that the most important and/or common fork blockage in 
nonstressed cells is caused by collisions with RNA polymerase, not template damage 
[57,64]. Collisions between replisomes and transcribing RNA polymerases lead to fork 
blockage in both bacteria and eukaryotes [29,65]. Cells have multiple protective 
mechanisms to reduce the complications due to these collisions and most collisions lead 
to pausing, not inactivation of the replisome [64].  
The orientation between the replisome and RNAP effects the extent of the 
damage. Head-on collisions are more inhibitory to replication forks than co-directional 
collisions [66,67,68,69,70,71]. Bacteria have evolved to minimize head-on collisions, by 
organizing the majority of highly-transcribed genes in the same orientation [72]. 
Reducing the frequency of RNAP stalling and backtracking reduces the frequency of 
collisions. Multiple RNAPs translocating on the same gene reduces the frequency of 
backtracking. Helicases, Rep and UvrD, are hypothesized to inhibit the frequency of 
RNAP backtracking [57]. After a collision has occurred, the E. coli replisome might be 
able to displace the stalled RNAP [73]. If the replisome is unable to displace stalled 
RNAP, Mfd, a dsDNA translocase, may be able to act [74]. Restart of the blocked 
replication forks can be initiated by PriA.  
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1.5.6 Tus Ter replication fork traps 
It is important to note that bacterial cells maintain a specialized and intentional 
fork-blockage system to assist in the completion of DNA replication. E. coli replication 
forks are paused, in a unidirectional fashion, when the forks encounter the Tus protein 
bound to Ter DNA sites in the terminus region [75,76,77]. When Tus binds to the Ter 
sites, a barrier called a fork trap is formed [78]. The fork trap allows forks to enter the 
terminus region, but they are not able to exit, creating stalled replication forks at the Ter 
site [79]. The Tus Ter system can be used to study the consequences of forks blocked at 
TBCs. When Ter sites are inserted in regions outside the terminus, RecBCD-mediated 
homologous recombination (HR) and induction of the SOS response are required to 
tolerate the blocked replication forks [80,81,82]. UvrD is also required for survival in this 
situation, which was traced to the ability of UvrD to remove the bound Tus from Ter sites 
[83,84]. 
1.5.7 Fork blockage by UV damage and DnaBts mutant 
Two other fork blockage systems have been studied in some detail and provide 
an interesting comparison to the systems described above. Following UV exposure, the 
replication machinery can be blocked by pyrimidine dimers [85,86]. RecA, along with 
loading factors RecF, RecO and RecR, are needed to stabilize the arrested replication 
fork after UV damage [87,88,89]. Furthermore, RecA-mediated HR is required for the 
processing of these blocked forks [27], and Rep helicase, along with primosome proteins 
PriB and PriA, are required for restarting replication [90]. The second system involves 
fork blockage after temperature shift of a DnaBts mutant, which can lead to the formation 
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of RuvABC-mediated DSBs [91]. In this case, the presence of RecA contributes to DSB 
formation, presumably by RecA-mediated Holliday junction formation for RuvABC action 
[92]. The forks stalled following DnaB inactivation are degraded by RecFOR, along with 
RecJ, RecG, and ExoI (SbcB) [93]. 
1.5.8 DNA-protein complexes in eukaryotes  
In Saccharomyces cerevisiae, the Fob-block system consists of Fob1 which 
binds to the replication fork barrier (RFB) site in ribosomal DNA (rDNA), preventing the 
replication fork from progressing in the wrong direction [94,95]. This system has been 
used as a model showing that overcoming DNA-protein complexes is also important in 
eukaryotic cells [96]. An inducible Fob-block system was used to show that MRX 
(Mre11, Rad50, and Xrs2) plays a role in maintaining fork integrity at these strong, but 
non-covalent protein-DNA barriers. In  E. coli, RecBCD, RecQ, and RecJ play roles 
similar to the MRX complex.  
In Schizosaccharomyces pombe, RTS1 is a terminator of replication that controls 
the direction of replication at the mat locus by creating an RFB site [97]. Using a system 
to express RTS1, it was discovered that homologous recombination is necessary for cell 
viability [98]. While the recombination is required for cell viability when forks are stalled, 
the recombination occasionally causes gross chromosomal rearrangements [98].  
1.6 Helicases clearing stalled replication forks  
Helicases play important roles in restarting stalled replication forks by displacing 
the blocks to replication. Rep and UvrD are helicases that translocate from 3′ to 5′  
[99,100]. Rep helicase allows replication fork progression past a protein-DNA complex 
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including E111G EcoRI protein blocks and TBC arrays [57]. Rep is also required for 
restarting replication stalled at UV-damage [90]. UvrD, like Rep, also allows replication 
fork progression past TBC arrays [57]. UvrD is capable of removing the bound Tus from 
Ter sites [83,84]. Rep, but not UvrD interacts with the replicative helicase to facilitate the 
replication of DNA with a bound protein [57]. Phage T4 Dda helicase is capable of 
clearing DNA bound by RNA polymerase (RNAP) in vitro [101]. 
1.7  Major questions to be addressed 
The scope of this work is to analyze effects of a solo TBC, using the mutant 
M.EcoRII protein (C186A) to compare to the consequences of TBCs and DPCs 
discussed in Chapter 1. We use 2D gel electrophoresis to determine if a single TBC can 
block replication forks in vivo, as was previously shown for covalent DPCs [43]. We 
compared a colletion of twenty-five mutants’ sensitivity to M.EcoRII-C186A TBCs with 
aza-C-induced DPCs. In addition to studying the effects of M.EcoRII-C186A TBCs, we 
have performed tests with quinolone antibiotics which stabilize the cleavage complex 
DPC. The same collection of mutants were tested for quinolone sensitivity.  
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Table 1: Functions of relevant genes  
gene function  
dinD function unknown; upregulated during SOS response 
dinG helicase 
dnaJ chaperone 
dnaQ epsilon subunit of DNA polymerase  
ftsK  essential cell division protein linking cell division and chromosome segregation   
helD helicase IV 
hflC  part of HflCK complex that regulate FtsH protease 
intQ predicted defective integrase 
lexA transcription repressor that regulates the SOS response 
mcrA component of restriction system for defending the cell against foreign DNA 
mfd  transcription-coupled repair factor 
polB DNA polymerase II; combined polymerase and exonuclease 
priA component of primosome 
rarA conserved ATPase involved in responses to fork stalling  
recA DNA strand exchange and recombination protein with protease and nuclease activity 
recB 
helicase;  component of the RecBCD helicase/nuclease (exonuclease V) complex that 
is essential for recombination and dsDNA break repair 
recC 
helicase;  component of the RecBCD helicase/nuclease (exonuclease V) complex that 
is essential for recombination and dsDNA break repair 
recD 
helicase;  component of the RecBCD helicase/nuclease (exonuclease V) complex that 
is essential for recombination and dsDNA break repair 
recF component of the RecFOR complex which functions in RecA-mediated recombination 
recG helicase; catalyzes branch migration on forked DNA structures 
recJ Exonuclease; functions with RecQ & RecFOR 
recO component of the RecFOR complex which functions in RecA-mediated recombination 
recQ Helicase; functions with RecJ & RecFOR 
recR component of the RecFOR complex which functions in RecA-mediated recombination 
rep helicase; removes proteins from DNA ahead of replication fork 
ruvA helicase; Holiday junction resolvasome 
ruvC endonuclease; Holiday junction resolvasome 
sbcCD dsDNA exonuclease and ssDNA endonuclease  
ssrA 
specialized tmRNA that releases stalled ribosomes and tags the truncated peptides for 
degradation 
uvrA subunit of the UvrABC NER generalized DNA repair process 
uvrD helicase II; also functions with NER 
xseA exonuclease VII 
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Chapter 2:  Functions that protect from tightly bound 
DNA-protein complexes created by mutant EcoRII 
methyltransferase 
2.1 Introduction  
2.1.1 M.EcoRII-C186A tightly-bound DNA-protein complexes 
As mentioned in chapter one, the mechanisms behind the lethality induced by 
solo TBCs have not been well studied, nor is it clear whether very tight binding but 
noncovalent complexes are processed in the same way as covalent DPCs. We used a 
system to express tight-binding mutant M.EcoRII protein (C186A), which creates solo, 
site-specific, and protein-specific TBCs, to analyze the in vivo consequences and protein 
requirements for survival. A powerful aspect of this system is that previous studies, from 
our lab and others, have already identified a variety of mutants that are hypersensitive to 
aza-C-induced DPCs that involve the same M.EcoRII protein (except that the DPCs 
utilize the wild-type version of the protein) [28,43,45,46,47,48,49] (reviewed in [42]; 
Krasich et al., unpublished data). The active site cysteine residue (C186) of M.EcoRII 
acts on a cytosine residue in the recognition sequence 5'-CCWGG by transferring the 
methyl group from S-adenosylmethionine [44]. When the active site cysteine residue is 
substituted with alanine, a TBC is formed between the mutant M.EcoRII and the EcoRII 
site containing the target cytosine [60]. Covalently trapped DPCs are formed at the same 
sites with the wild-type M.EcoRII when the cytidine analog, aza-C, has replaced the 
target cytosine [60,102,103].  
We performed an extensive candidate gene screen for mutants that are 
hypersensitive to the M.EcoRII-induced solo TBCs, using an arabinose expression 
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system that allows carefully titrated expression of M.EcoRII. We found several gene 
products necessary for protection against these TBCs that are known to also protect 
against DPCs induced with wild-type M.EcoRII (after aza-C incorporation): RecA, 
RecBC, RecG, RuvABC, UvrD, FtsK, and SsrA (tmRNA). In contrast, a functional 
RecFOR pathway and Rep helicase are needed for protection against TBCs but not 
DPCs induced by M.EcoRII-C186A. Overall, our results support a model in which 
RecFOR/RecA-dependent fork stabilization promotes dissociation of a TBC, and also 
reveal that the tmRNA system helps protect against TBCs, presumably helping to 
overcome TBC-mediated blockage of coupled transcription-translation complexes. 
Interestingly, different but overlapping functions are involved in surviving TBCs versus 
DPCs, both involving the M.EcoRII protein. 
2.1.2 Replication intermediates on 2D gel electrophoresis 
2D gel electrophoresis allows for the separation of DNA intermediates based on 
size and shape [104]. Previous work from our lab used 2D agarose gel electrophoresis 
to visualize the accumulation of replication forks blocked at aza-C-induced DPCs 
involving the wild-type M.EcoRII protein [43]. The site-specific DPCs between M.EcoRII 
and its recognition sequence create specific bubble molecules detected as spots on the 
2D gel. A mutation that eliminates an EcoRII methylation site leads to disappearance of 
the corresponding spot. 2D gel electrophoresis has been used to visualize fork-blockage 
following UV-damage, but because the damage is not site-specific, the pattern that can 
be seen is less distinct, involving a cone-shaped region [105]. We replicated the 2D gel 
electrophoresis technique used for aza-C-induced DPCs [43] and determined that a 
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single, tightly bound (but non-covalent) M.EcoRII complex could also block replication 
forks in vivo. Interestingly, based on the molecular forms observed, the downstream 
consequences of fork blockage are different depending on whether M.EcoRII is in a 
covalent or non-covalent complex on the DNA.  
2.2 Results  
2.2.1 Fork blockage at TBCs created by M.EcoRII-C186A  
2D gel electrophoresis was used to visualize DNA replication intermediates to 
determine whether a single tightly bound (but non-covalent) M.EcoRII complex could 
block replication forks (Figure 5). We found an accumulation of bubble molecules at 
locations consistent with the EcoRII methylation sites at 1,443 and 1,060 bp (and less 
convincingly at 131 bp) (Figure 5). The spot corresponding to the 1,443-bp recognition 
site was consistently stronger than the other two, suggesting that M.EcoRII sites may be 
saturated with the mutant M.EcoRII protein, leading to more frequent fork blockage at 
sites that are encountered earlier in replication of the plasmid (i.e. close to the replication 
origin; note that the M.EcoRII site at position 2,501 is very close to the origin - we do not 
know whether forks are blocked at that site, since the resulting bubble spot would be 
difficult or impossible to detect in the vicinity of the very intense monomer spot). The 
spots on the bubble arc were only detected with the addition of arabinose to induce 
expression of M.EcoRII-C186A. To directly test whether TBC formation at M.EcoRII sites 
was leading to the blocked replication forks, we analyzed a mutated pBR322-C1060A 
plasmid, which lacks the methylation site at 1,060 bp. Indeed, the bubble spot 
corresponding to the 1,060-bp site disappeared while the spot corresponding to the 
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1,443-bp site remained, confirming that the accumulation of bubble molecules is due to 
blockage at EcoRII methylation sites. We conclude that solo TBCs involving the mutant 
M.EcoRII protein are capable of blocking replication forks in vivo, as do DPCs formed 
after aza-C treatment with wild-type M.EcoRII.  
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Figure 4:  Predicted replication intermediates and two-dimensional gel 
pattern of linearized pBR322. 
The diagram on the left depicts plasmid pBR322 linearized by PstI at 3,607 bp; 
leftward arrows, replication start site (2,535 bp). Inverted triangles, EcoRII methylation 
sites (at positions 131, 1,060, 1,443, 2,501, 2,622, and 2,635 bp from left to right); 
diamond, tightly bound MTase at a blocked fork. The diagram on the right depicts B, 
bubble; DY, double Y; X, X structures; OC, open circle; LM, linear monomer; star, 
replication intermediate blocked at the 1,060 methylation site and the resulting 
accumulation on the two-dimensional gel. This figure is modified from Kuo et al. [43]. 
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Figure 5:  DNA replication is blocked in cells expressing mutant EcoRII 
C186A methyltransferase. 
DNA was digested with Pst1-HF, run on two-dimensional gel electrophoresis and 
visualized with Southern hybridization. Closed arrows show accumulation of bubble 
molecules at locations consistent with the EcoRII methylation sites at 131, 1,060, and 
1443 bp. Open arrow shows disappearance of the 1,060 bp spot with the mutated 
pBR322-C1060A plasmid. 
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2.2.2 Functions that protect from TBCs created by M.EcoRII-C186A 
To determine which proteins play a role in protecting from the damage created by 
TBCs induced by M.EcoRII-C186A, a collection of knockout mutants was created in a 
genetic background that allows carefully titrated expression from an arabinose promoter. 
We then compared sensitivities by examining growth (or lack thereof) in the presence of 
increasing concentrations of arabinose. The collection was largely chosen based on 
known roles of the corresponding proteins in protection from DPCs or other damage that 
leads to stalled replication forks. The proteins could be involved in directly reversing the 
TBC, protecting from the immediate consequences of the TBC (e.g. restarting replication 
forks or dealing with stalled transcription/translation), or repairing downstream damage 
from the TBCs (e.g. broken replication forks). 
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Figure 6:  Sensitivity to M.EcoRII‐C186A 
Overnight cultures of BW27783 (wild-type) and the indicated BW27783 
derivatives, containing plasmid pBAD-MEcoRII-C186A, were serial diluted five-fold and 
spotted onto LB plates containing chloramphenicol with either glucose (0.01%) or 
arabinose (0.0003%, 0.001%, 0.003%, or 0.01%) and incubated at 37 overnight. Those 
mutants deemed to be hypersensitive are indicated with an asterisk. 
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2.2.3 Recombination proteins and sensitivity to TBCs 
Recombination and repair proteins play important roles in survival from damage 
due to DPCs and topoisomerase cleavage complexes. For example, RecA, which 
catalyzes strand exchange, and RecBCD, which prepares broken ends for HR, greatly 
improve survival from aza-C-induced DPCs [23,55,56,58,63] (Krasich et al., unpublished 
data) and quinolone-induced cleavage complexes [106,107] (also see Chapter 3). HR by 
RecA is also required for the processing of replication forks blocked at UV-induced 
pyrimidine dimers [27]. We found that recA, recB and recC mutants were all markedly 
sensitive to TBCs generated by expression of M.EcoRII-C186A (Figure 6). Therefore, 
DSBs are apparently generated after formation of both DPCs and TBCs. RecA and 
RecBCD may play a direct role in repairing DNA-protein complexes (presumably with 
DSB formation), or alternatively, these proteins may be involved in repairing downstream 
DNA damage such as replication forks that are broken after fork blockage (Figure 1).  
Like RecBCD, RecFOR assists in RecA-mediated recombination, but RecFOR 
proteins target RecA to single-stranded gaps rather than DNA ends [48,66]. The action 
of RecF, RecO and RecR stabilize and maintain replication fork arrest at sites of UV 
damage, while RecJ exonuclease and RecQ helicase can degrade nascent lagging 
strand DNA at the blocked fork [87,88,89,105,108]. We found that recF, recO and recR 
mutants are hypersensitive to TBCs induced by M.EcoRII-C186A (Figure 6). Notably, 
past studies showed that recFOR mutants are not sensitive to aza-C-induced DPCs [47] 
(Krasich et al., unpublished data), nor are they sensitive to quinolones [107]; also see 
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below). Perhaps fork stabilization by RecFOR is particularly beneficial in the case of 
non-covalently attached proteins (see Further Discussion; Figure 7). Mutants without 
RecJ or RecQ showed little or no sensitivity to M.EcoRII-C186A-induced TBCs, 
indicating that erosion of the nascent lagging strand is not relevant to the processing 
pathway (Figure 6; the recJ and recQ mutants sometimes appeared to be very slightly 
sensitive, but not in a convincing and reproducible manner). 
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Figure 7:  Model of involvement of RecFOR, RecA, and Rep in TBC repair 
This pathway involves the response to a replication fork that is blocked by a TBC. 
C186A Mtase: M.EcoRII-induced TBC, A: RecA, FOR: RecFOR, Rep: Rep 
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RuvA and RuvC are subunits of the Resolvasome, which resolves Holliday 
junctions and contributes to rescue of blocked DNA replication forks through replication 
fork reversal [52,69]. RuvA and RuvC knockout mutants are hypersensitive to aza-C-
induced DPCs [48] (Krasich et al, unpublished data) and to quinolone-induced cleavage 
complexes [65,70]. RuvAB-mediated fork regression does not appear to be involved in 
rescuing forks blocked by UV damage [109], however ruvAB and ruvC mutants 
accumulate unresolved Holliday junctions after UV treatment, leading to decreased cell 
viability [110]. We found that ruvA and ruvC mutants are hypersensitive to TBCs induced 
by M.EcoRII-C186A (Figure 6). Together with the evidence for TBC-induced fork 
blockage and hypersensitivity of recBC mutants (see above), we speculate that TBC-
blocked replication forks are sometimes cleaved by a nuclease to generate broken forks, 
which need to be repaired by RecBCD- and RuvABC-dependent HR. In this view, the 
hypersensitivity of ruvA and ruvC mutants suggests that some other nuclease is 
responsible for fork cleavage. An alternative explanation is that RuvABC induces fork 
cleavage (see [92]), with subsequent RecBCD-dependent HR, and that this fork 
cleavage/repair pathway is somehow important for overcoming the blocking TBC (e.g. by 
promoting removal of the tight-binding protein).  
2D gel electrophoresis was used to visualize the replication intermediates of a 
ruvC mutant. We found an accumulation of bubble molecules at locations consistent with 
the EcoRII methylation sites at 1,443 bp and less convincingly at 1,060 bp (Figure 8). 
The spot corresponding to the 131-bp recognition site was not visible and is possibly 
covered by another spot, unrelated to M.EcoRII-C186A expression. When the pBR322-
C1060A plasmid, which lacks the methylation site at 1,060 bp, was used, the bubble 
  
 
32
spot corresponding to the faint 1,060-bp site disappeared while the spot corresponding 
to the 1,443-bp site remained, confirming that the accumulation of bubble molecules is 
due to blockage at EcoRII methylation sites. In all conditions, there is an accumulation of 
X structures, consistent with unresolved Holliday junctions expected in a ruvC mutant. 
The X structures are not dependent on M.EcoRII-C186A expression, and there is no 
obvious increase in its intensity with TBC formation. Due to the M.EcoRII hypersensitivity 
of the ruvC mutant, we expected to see an increase in X structures with arabinose 
addition. Perhaps the number of blocked and then cleaved forks created by TBCs are 
too few to cause a detectable increase in X structures. 
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Figure 8:  Accumulation of unresolved Holliday junctions in ruvC mutant. 
DNA was digested with Pst1-HF, run on two-dimensional gel electrophoresis and 
visualized with Southern hybridization. Closed arrows show accumulation of bubble 
molecules at locations consistent with the EcoRII methylation sites at 1,443, and 1,060. 
Open arrow shows disappearance of the 1,060 bp spot with the mutated pBR322-
C1060A plasmid. X shows an accumulation of X structures. 
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One candidate for a nuclease that might cleave blocked forks, or even DNA near 
the tightly bound protein, is SbcCD. This protein has double-strand DNA exonuclease 
activity as well as single-strand DNA endonuclease activity [111], and has been shown 
to cleave palindromic branched DNA [112] as well as DNA near a tightly bound protein 
(streptavidin bound at biotin-tagged DNA end) [113]. We found that sbcD mutants are 
not hypersensitive to TBCs induced by M.EcoRII-C186A (Figure 6). Knockouts of SbcCD 
also display wild-type sensitivity to aza-C-induced DPCs (Krasich et al., unpublished 
data). 
2.2.4 Helicases and sensitivity to TBCs 
Helicases function in diverse cellular processes, and multiple studies implicate 
various helicases in responding to DNA-bound proteins. For example, Rep helicase 
allows replication fork progression past a protein-DNA complex [57,114,115], and also 
prevents the formation of DSBs following replication forks arrest [116]. UvrD helicase 
functions in NER and MMR and can remove the replication terminator protein, Tus, 
bound at Ter sites or RecA protein from filaments [83,84,117]. We found that strains 
lacking either Rep or UvrD helicase are hypersensitive to TBCs induced by M.EcoRII-
C186A, with the rep mutant being the more hypersensitive of the two (Figure 6). 
Notably, the response to aza-C-induced DPCs involving M.EcoRII was distinct, 
with uvrD mutants being hypersensitive, but not rep mutants [48] (Krasich et al., 
unpublished data). Given Rep’s well-studied ability to remove proteins bound to DNA, it 
seems likely that Rep removes the mutant M.EcoRII from TBCs but is unable to remove 
M.EcoRII from aza-C-induced DPCs, due to the covalent linkage (see Discussion). A 
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knockout of UvrA, which functions in nucleotide excision repair, is not sensitive to TBCs 
induced by M.EcoRII-C186A, demonstrating that some UvrD function outside of NER is 
important. Likewise, a UvrA knockout is not hypersensitive to aza-C-induced DPCs, 
excluding NER as an important component of DPC repair with these lesions 
[45,46,48,118] (Krasich et al., unpublished data). 
RecG helicase functions in DSB repair and can catalyze branch migration of 
forked DNA structures and Holliday junctions [26,27]. RecG mutants are hypersensitive 
to both M.EcoRII-C186A-induced TBCs (Figure 6) and aza-C-induced DPCs [48] 
(Krasich et al., unpublished data). The role of RecG could involve branch migration 
during RecBCD-mediated DSB repair, and/or modulation of blocked replication forks.  
HelD is a helicase that functions in the RecF pathway of HR [119]. Even though 
the RecF pathway appears to be important in surviving TBCs induced by M.EcoRII-
C186A, a helD knockout was not hypersensitive (Figure 6). Finally, DinG helicase has a 
poorly understood role in DNA repair and replication [120]. We found that a dinG 
knockout is not hypersensitive to TBCs induced by M.EcoRII-C186A (Figure 6), but we 
recently showed that it is hypersensitive to aza-C-induced DPCs (Krasich et al., 
unpublished data), consistent with a special role in repairing DNA-protein crosslinks. 
Mfd, the transcription-coupled repair factor in bacteria, removes RNA polymerase 
stalled at DNA damage, such as UV-induced pyrimidine dimers, and recruits the 
nucleotide excision repair machinery [121]. Mfd is unable to promote fork movement 
through the TBC generated by a tight-binding restriction nuclease mutant (EcoRI-
E111G) in vitro [57], but it does somehow promote the rapid recovery of gene 
expression following UV-induced DNA damage [122]. An Mfd knockout mutant is not 
  
 
36
hypersensitive to TBCs induced by M.EcoRII-C186A (Figure 6). We previously found 
that inactivation of Mfd also does not cause hypersensitivity to aza-C-induced DPCs, 
arguing that it plays no unique role in releasing RNA polymerase stalled at DPCs 
[48,49]. 
2.2.5 FtsK and SsrA (tmRNA) protect against TBCs  
We tested a number of other knockout mutants, involved in diverse cellular 
functions that could conceivably play a role in protecting cells from TBCs. FtsK is an 
essential cell division protein linking cell division and chromosome segregation. We 
previously isolated an ftsK insertion mutant in a transposon mutagenesis screen for 
mutants hypersensitive to aza-C-induced DPCs (Krasich et al., unpublished data). The 
location of ftsK in E. coli K12 is nucleotide 933224 through 937213. The last nucleotide 
in the transposon mutants is 937143 (2% disrupted) and 934308 (75% disrupted). The 
essential N-terminal 210 amino acids are contained in both mutants. These mutants are 
expected to be viable, but unable to stimulate XerCD recombination [123]. Here, we find 
that the ftsK insertion mutant is also hypersensitive to TBCs induced by M.EcoRII-
C186A (Figure 6). Hypersensitivity could reflect some important role in segregation of 
chromosomes after damage, for example assisting XerCD in chromosome dimer 
resolution following HR induced by DPCs or TBCs (Figure 9). Alternatively, FtsK is 
capable of stripping proteins off DNA in vitro [124] and perhaps has a function in 
removing the tightly-bound M.EcoRII-C186A protein (Figure 9). 
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Figure 9:  Two models of involvement of FtsK in TBC repair 
1. Removal of M.EcoRII-C186A-induced TBC. 2. Chromosome dimmer resolution 
with XerCD (modified from [125]) 
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SsrA (tmRNA) releases stalled ribosomes from the end of an mRNA lacking a 
stop codon. We showed previously that ssrA mutants are hypersensitive to aza-C-
induced DPCs, arguing that tmRNA plays an important role in clearing stalled ribosome-
mRNA complexes generated after transcription is blocked by aza-C-induced DPCs [49]. 
Likewise, we find that an ssrA knockout mutant is hypersensitive to TBCs induced by 
M.EcoRII-C186A (Figure 6). We therefore propose that M.EcoRII-C186A, bound to its 
recognition sites, can block RNA polymerase and the coupled translation machinery in 
much the same way as covalently attached M.EcoRII (Figure 10). 
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Figure 10:  “Chain-reaction” model for clearing blocked elongation 
complexes 
SsrA (tmRNA) clearing stalled ribosome-mRNA complexes generated after 
transcription is blocked by M.EcoRII-C186A-induced TBC. C186A Mtase: M.EcoRII-
induced TBC, RNAP: RNA Polymerase 
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Both dnaJ and hflC mutants are hypersensitive to aza-C-induced DPCs [49]. 
Either or both of these proteins could potentially function in processing the protein within 
DPCs, since DnaJ is a chaperone that assists in protein folding, while HflC is part of the 
HflK-HflC complex which interacts with FtsH to regulate the degradation of various 
proteins [126,127]. We found that neither dnaJ nor hflC knockout mutants are 
hypersensitive to M.EcoRII-C186A (Figure 6), suggesting that DnaJ and HflC might play 
a special role in degrading covalently bound proteins that cannot be dislodged by a 
helicase (see Discussion). 
XseA is the large subunit of Exonuclease VII (ExoVII) [128], and ExoVII-deficient 
mutants are sensitive to both UV irradiation [129] and nalidixic acid [130], for unknown 
reasons. We found that an xseA mutant shows wild-type levels of sensitivity to the TBCs 
induced by M.EcoRII-C186A (Figure 5). Finally, DNA polymerase II (Pol II; encoded by 
polB) functions as a polymerase and exonuclease with roles in replication restart 
following UV exposure, translesion synthesis and nucleotide excision repair (NER) 
[131,132,133,134,135]. Knockout mutants in polB are not hypersensitive to TBCs 
induced by M.EcoRII-C186A (Figure 6). Pol II also does not contribute to survival, 
mutagenesis, or restoration of DNA synthesis following UV irradiation [136] or survival 
from aza-C-induced DPCs [48].  
 
2.2.6 Conflicting results between two rarA knockouts  
RarA is a highly conserved DNA-dependent ATPase, with orthologs Mgs1 (yeast) 
and Wrnip1 (mammal) which are involved in replication fork stability [137]. They are 
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classified in the clade of "clamp loader" AAA+ proteins based on DNA sequence and 
structure [138,139,140]. Studies suggest that RarA and RecA are functionally redundant 
in rescuing stalled replication forks [141]. RarA colocalizes with SeqA and RecQ at the 
replication fork, possibly rescuing stalled replication forks [142]. Previously, the only 
phenotypes observed in a rarA knockout also require xer or dif mutations. We have 
discovered that the BW27784 ∆rarA knockout, created by P1 transducing a rarA::Kan 
construction created in the Mike Cox lab, is hypersensitive to M.EcoRII-C186A induced 
TBCs (Figure 11). However, the Keio collection rarA knockout was not sensitive to the 
M.EcoRII-C186A induced TBCs (Figure 11).  
We tried to clarify these contradictory results using a complementation test. 
Plasmid pEAW354, a rarA overproduction vector, was transformed into the BW27784 
∆rarA Cox lab knockout. Based on plasmid pET-21a, pEAW354 has a T7 promoter and 
requires T7 RNA polymerase for full expression. We attempted complementation, relying 
only on leaky expression, in the absence of T7 RNA polymerase. The negative result we 
obtained, of the plasmid failing to compliment the rarA knockout, is unfortunately not 
conclusive (Figure 11). Surprisingly, the Keio rarA knockout actually seemed to be 
resistant to arabinose treatment. Further studies are needed to investigate the possible 
role of RarA in response to TBCs. 
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Figure 11:  Sensitivity of ∆rarA mutants to M.EcoRII-C186A 
Overnight cultures of BW27783 (wild-type) and the indicated BW27783 
derivatives, all containing plasmid pBAD-MEcoRII-C186A, and plasmid pEAW354 when 
indicated, were serial diluted five-fold and spotted onto LB plates containing 
chloramphenicol with either glucose (0.01%) or arabinose (0.003%) and incubated at 37 
overnight.  
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2.3 Discussion 
In this work, we analyzed fork-blockage by M.EcoRII-C186A-induced TBCs, and 
the sensitivities of candidate mutants. A powerful aspect of our system is the ability to 
compare aza-C-induced DPCs involving wild-type M. EcoRII with M.EcoRII-C186A-
induced TBCs, formed at the same M.EcoRII DNA recognition sequence. Using the 
same 2D gel electrophoresis technique employed for the aza-C-induced DPCs [43], we 
can directly compare the replication intermediates formed in the presence of DPCs and 
TBCs. We determined that an M.EcoRII-C186A-induced TBC could also block 
replication forks in vivo (Figure 5).  
Strikingly, the 2D gel patterns after aza-C-induced DPC formation with wild-type 
M.EcoRII [43] showed two prominent features that were not seen here after TBC 
formation with M.EcoRII-C186A. First, aza-C-induced DPCs caused an accumulation of 
RecA-dependent X structures, presumably due to RecA-dependent recombination or 
replication fork regression. Second, a prominent Y-arc with spots was seen after DPC 
formation, and attributed to the induction of rolling-circle replication (confirmed by EM 
analysis; [43]). These results indicate that DPCs lead to more frequent fork breakage 
than TBCs.  
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Table 2:  Proposed models for involvement in repair of M.EcoRII-C186A-
induced TBCs, quinolones, and aza-C-induced DPCs 
This table summarizes the proposed models for involvement in repair of 
M.EcoRII-C186A-induced TBCs, quinolones, and aza-C-induced DPCs. X indicates that 
proposed model applies. 
 
 
  
M.EcoRII-
C186A-
induced 
TBCs Quinolones
aza-C-
induced 
M.EcoRII 
DPCs  
 
 
 
Proposed model for involvement 
DinG     X  prevent replication/transcription collisions 
DnaJ   X 
processing the protein within DPCs; chaperone 
that assists in protein folding 
FtsK  X X X 
stripping a protein from DNA or role in assisting 
XerCD in chromosome dimer resolution 
HflC      X 
processing the protein within DPCs; involved in 
regulation of protein degradation 
RecA X X X homologous recombination 
RecBCD X X X 
RecBCD assisted RecA-HR may play a direct role 
in repairing DNA-protein complexes or repairing 
downstream DNA damage such as replication 
forks that are broken after fork blockage 
RecFOR X     
RecFOR assisted RecA-HR or stabilization of 
stalled replication fork 
RecG X X X 
branch migration following RecA-HR or 
modulation of blocked replication forks 
Rep X X   removal of protein 
RuvABC X X X Holliday junction resolution following RecA-HR 
SsrA X   X clearing blocked elongation complexes 
UvrD X X X 
removal of RNAP following SsrA clearing blocked 
elongation complexes 
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Based on this study of TBCs induced by M.EcoRII-C186A and past studies of 
aza-C-induced DPCs induced by wild-type M.EcoRII, we now have a direct comparison 
of cellular functions that protect against the same tightly bound protein in either non-
covalent or covalent form (summarized in Table 4, Chapter 4). Several gene products 
are needed for protection against both kinds of complexes, notably RecA, RecBC, 
RecG, RuvABC, UvrD, FtsK, and SsrA (tmRNA). The first group of functions could play 
key roles in processing blocked replication forks or downstream DNA breaks resulting 
from blocked forks, given that both kinds of M.EcoRII complex block replication forks 
(Figure 5; [43]). Involvement of the tmRNA pathway indicates that both kinds of complex 
also block the coupled transcription-translation machinery (see [49]). We have 
speculated on the possible roles of FtsK above. 
A very notable difference was observed between the responses to the two kinds 
of M.EcoRII complexes: the RecFOR pathway is important in the response to TBCs 
induced by M.EcoRII-C186A but not to DPCs induced by aza-C with the wild-type 
protein. By analogy with the role of RecFOR in response to UV damage, we infer that a 
pathway of fork protection (by RecFOR and RecA) after blockage by the TBC sometimes 
allows a productive replication restart event – perhaps by inducing helicase-driven 
dissociation of the blocking M.EcoRII-C186A (presumably by Rep, possibly with 
assistance from UvrD). Note that the rep knockout mutant was uniquely sensitive to 
TBCs induced by M.EcoRII-C186A, and that Rep helicase has previously been shown to 
play roles in dissociation of proteins from DNA (see Introduction). 
These genetic results are consistent with the physical analyses of replication 
intermediates resulting from the two kinds of complexes. While both TBCs and DPCs 
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lead to fork blockage (accumulation of bubble molecules), only the DPCs led to Y forms 
and X structures (Figure 5; [43]). Therefore, the ability of the RecFOR pathway to 
stabilize the forks stalled by TBCs may minimize fork breakage and permit Rep to 
dissociate the TBC.  
Replication forks are blocked by both a single TBC induced by M.EcoRII-C186A 
and arrays of TBCs created with tandem repressor-operator complexes (Figure 5; [55]) . 
Inactivation of RecA, RecBCD, or RecG causes sensitivity to both types of TBC, 
implying that DSBs are formed in both systems following replication blocks (Figure 6; 
[56]). It is also interesting to note that Rep and UvrD play redundant roles in surviving 
the 34-copy TBC arrays consisting of transcription factors, with only the double knockout 
mutant showing a phenotype [57], while each single mutant is sensitive to TBCs induced 
by M.EcoRII-C186A. This is consistent with the possibility that UvrD plays some other 
important role in survival after formation of TBCs induced by M.EcoRII-C186A. It is very 
interesting that RecFOR and RuvABC protect from TBCs induced by M.EcoRII-C186A, 
but not from arrays of TBCs created with tandem repressor-operator complexes (Figure 
6; [56]). This suggests that fork stabilization by RecFOR is not important in rescuing 
forks blocked by tandem repressor-operator complexes. Further studies are needed to 
deduce whether these differing protein requirements relate to the tandem nature of the 
arrayed TBCs or perhaps to the different binding strength of the two kinds of protein 
(very tight binding mutant M.EcoRII versus weaker binding transcription factors). 
A direct comparison of sensitivity to M.EcoRII protein within DPCs versus TBCs 
also revealed a novel role for both DinG helicase and HflC chaperone in survival after 
DPC formation. These two proteins apparently play some special role that is dictated by 
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the existence of the covalent DNA-protein bond. One possibility is that they act directly 
on the DPC, perhaps with DinG playing a role in DPC recognition along the DNA and 
HflC acting on the covalently bound protein after recognition. A different interpretation is 
that one or both play some unique role in rescuing the more frequent fork breakage 
events that appear to occur with the DPC. 
2.4 Materials and Methods 
2.4.1 Materials 
Restriction enzymes were from New England Biolabs; Nytran membranes from 
Schleicher & Schuell; QuickChange Mutagenesis Kit from Stratagene; Random Primed 
DNA Labeling Kit from Roche Applied Science; and radiolabeled nucleotides from 
Perkin-Elmer Life Science. LB (Luria broth) contained bacto tryptone (10 g/L), yeast 
extract (5 g/L), and sodium chloride (10 g/L).  
2.4.2 Plasmids 
Plasmid pBAD-MEcoRII contains the wild-type M.EcoRII coding sequence 
between the KpnI and SphI sites in the multiple cloning region of pBad33, downstream 
of the araBAD promoter [49]. Plasmid pBAD-MEcoRII contains a chloramphenicol 
resistance gene and is based on the pACYC184 replicon. Plasmid pBAD-MEcoRII-
C186A, containing the active site mutant version of the M.EcoRII coding sequence, was 
created by mutating the active site cysteine codon of M.EcoRII within plasmid pBAD-
MEcoRII using Stratagene QuickChange Mutagenesis Kit [60]. Plasmid pBR322-
C1060A is a derivative of pBR322 with a cytosine to adenine mutation at location 1060, 
destroying one M.EcoRII recognition site in the plasmid [43]. Plasmid  pEAW354, which 
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contains rarA inserted between the NdeI and BamHI sites of vector pET21A (Novagen) 
along with ampicillin resistance gene, was obtained from the Mike Cox lab (University of 
Wisconsin, Madison). 
2.4.3 E. coli strains 
Strain BW27783 [F-, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), λ-, ∆(araH-
araF)570(::FRT), ∆araEp-532::FRT, φPcp8araE535, rph-1, ∆(rhaD-rhaB)568, hsdR514)] 
allows for homogenous and titratable expression from pBAD vectors [143] and was 
obtained from the lab of HP Erickson (Duke University). E. coli knockout mutants from 
the Keio collection [144] contain kanamycin resistance gene inserts, and are identified in 
this thesis as ∆ followed by gene name (e.g. ∆recA). E. coli transposon mutants 
(kanamycin resistance gene) were created in a recent genetic screen (Krasich et al., 
unpublished data; also see [49]) and are identified here as insertions (e.g. ssrA::Kan). In 
each case, the desired mutation was moved into the BW27783 background via P1 
transduction [145], selecting for kanamycin resistance, and confirmed by PCR. The 
kanamycin-resistance cassette was not removed from the tested strains. The recF4115 
missense mutant (K36Q) was moved into BW27783 using P1 transduction, selecting for 
a linked Tn10 marker (in tnaA; [146]); transductants were screened by DNA sequencing 
for co-transduction of the recF mutation. The RarA knockout strain was created by P1 
transducing the rarA mutation from EAW98 (obtained from the Mike Cox lab; MG1655 
∆rarA) into BW2783. The rarA gene is replaced from start codon to stop codon with FRT 
sites and a Kanamycin resistance gene.  
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2.4.4 2D gels to visualize DNA intermediates 
Replication intermediate were visualized by 2D gel electrophoresis using a 
procedure similar to that of Kuo et al [43]. Overnight cultures of BW27783 containing 
plasmid pBAD-MEcoRII-C186A and either pBR322 or pBR322-C1060A were grown with 
and without 0.01% glucose until OD560 = 0.3. Arabinose (0.00005%) was then added to 
the no-glucose culture and 4-mL samples were collected after 60 min at 37C. Samples 
were pelleted and frozen at -80C. Cell pellets were resuspended in 500 µL of Triton 
lysis butter [50 mM Tris-HCl (pH 7.8), 10 mM EDTA, 1% Triton X-100, and lysozyme at 
1.8 mg/mL] and incubated at 65C for 20 min. Proteinase K (0.5 mg/mL) and SDS 
(0.2%) were added to the samples and incubated at 55 C for 1 h. DNA was extracted 
with phenol/chloroform/isoamyl alcohol (25:24:1) and dialyzed against TE [10 mM Tris-
HCl (pH 7.8), 1 mM EDTA] at 4C overnight. The DNA (50 µL) was digested with Pst1-
HF for 2 h at 37C. Digested DNA was separated by size in the first dimension gel (0.4% 
agarose) run in 0.5X Tris-borate EDTA (TBE) buffer at 1 V/cm for 29 hours. The desired 
slices were cut from the gel, rotated 90 counterclockwise, and cast within the top of the 
second-dimension gel (1% agarose with ethidium bromide at 0.3 ug/mL). The second 
dimension gel was run at 4.5 V/cm for 15 hours at 4 C with recirculated 0.5X TBE 
containing ethidium bromide (0.3 µg/mL). The gels were analyzed by Southern 
hybridization with a 1,158-bp gene probe from pBR322 that does not hybridize with 
plasmid pBAD-MEcoRII-C186A. The probe was generated by PCR amplification from 
plasmid pBR322 using primers 5’-CGGTATTCGGAATCTTGCAC-3’ and 5’-
AGCTCGTTGAGTTTCTCCAG-3’ and purified using the DNA Clean & Concentrator Kit 
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(Genesee Scientific). The probe was 32P-labeled using the Random Primed DNA 
Labeling Kit (Roche Applied Science). Southern blots were visualized by 
PhosphorImager.  
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Chapter 3: E. coli response to quinolone antibiotics 
3.1 Introduction 
Topoisomerases are enzymes that regulate topology (underwinding or 
overwinding) of DNA. To regulate the topology, topoisomerases bind the DNA and cut 
the phosophodiester backbone. Type II topoisomerases create two staggered cuts 
covalently attached at their 5’ ends to the topoisomerase in a reaction intermediate 
known as the cleavage complex. The cleavage complex allows topoisomerase to pass 
another segment of double-stranded DNA through the transient break to correct the DNA 
topology and once complete, the DNA backbone is resealed (for reviews, see [147]).  
In eukaryotes, topoisomerase II can be inhibited by chemotherapeutic drugs, 
including doxorubicin and etoposide, that stabilize the cleavage complex. There is 
evidence that this stabilization of the cleavage complex is necessary for the cytotoxicity 
[148]. In our lab, studies with phage T4 showed that replication forks were blocked at the 
site where the chemotherapeutic drugs stabilized the cleavage complex [149]. 
In E. coli, topoisomerase IV [50] and topoisomerase II (gyrase) [51,52] are 
inhibited by the quinolones antibiotics. Quinolones stabilize the cleavage complex, which 
is a unique form of DPC. Like aza-C-induced DPCs and M.EcoRII-induced TBCs, 
quinolone-stabilized DNA gyrase cleavage complexes block replication forks in vivo [53]. 
The mechanism(s) by which quinolone-stabilized cleavage complexes lead to DSB 
formation and ultimately cell death have been extensively studied but are still not well 
understood at the molecular level. The formation of the cleavage complex is necessary 
for the cytotoxicity of quinolones (for reviews, see [112,113,114,115]). However, 
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formation of the cleavage complex is not sufficient to cause cell death. Cytotoxicity likely 
results from the conversion of cleavage complexes into a DNA break, but the 
mechanism of break formation is not known [150]. The cleavage complexes are 
reversible upon drug removal both in vivo and in vitro [111,116]. Blocking protein 
synthesis with chloramphenicol protects from the cytotoxic action of nalidixic acid [151], 
implying that production of a protein is necessary for cytotoxicity.  
There is much evidence that the cytotoxic lesion from quinolones is a DSB, 
including that a functional RecBCD helicase/ nuclease complex is necessary for the 
induction of SOS in response to quinolones [21] and recBCD mutants are hypersensitive 
to quinolones [106]. As discussed in Chapter 1, RecBCD processes DSBs to allow for 
RecA-mediated repair. Chromosomal breaks have also been seen after nalidixic acid 
treatment [152], but these breaks are likely not the same break at the cleavage complex, 
as the cleavage complex alone is not sufficient for cytotoxicity [150]. One model for how 
the quinolone-stabilized cleavage complex leads to a DSB is that a nuclease such as 
SbcCD cleaves the DNA adjacent to the DPC [113]. SbcCD has double-strand DNA 
exonuclease activity as well as single-strand DNA endonuclease activity [111], and has 
been shown to cleave palindromic branched DNA [112] as well as DNA near a tightly 
bound protein (streptavidin bound at biotin-tagged DNA end) [113]. Further support for 
this model is evidence that Mre-Rad50 nuclease complex can cleave DNA next to a 
DPC created with the meiotic recombination initiator protein Spo11 in Saccharomyces 
cerevisiae [153]. Another model, shown in phage T4 for a different topoisomerase 
inhibitor, is the "collateral damage model" where recombination nucleases that act on 
the forks blocked at the cleavage complex create the DNA breaks [154]. Finding novel 
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mutants with unique quinolone responses would be useful in uncovering more about the 
molecular mechanisms of quinolone cytotoxicity. 
3.1.1 Is replication necessary for the cytotoxicity of quinolones? 
There are contradictions in the literature about the necessity of replication for 
cytoxicity of quinolones. Gudas and Pardee used a temperature-sensitive dnaA mutant, 
unable to initiate new rounds of replication, to show that DNA replication is necessary for 
the induction of the SOS reponse by nalidixic acid [155]. However, Sassanfar and 
Roberts used a temperature-sensitive dnaC mutant which cannot load the replicative 
helicase, DnaB, and showed that nalidixic acid can still induce SOS without ongoing 
DNA replication [156]. Zhao et al. used a temperature-sensitive dnaB mutant, and 
showed that ongoing DNA replication is not required for killing by nalidixic acid [157]. It is 
plausible that DNA replication is necessary for killing by quinolones, because the 
quinolone-stabilized DNA gyrase cleavage complexes have been shown to block 
replication forks in vivo [53]. To clarify the conflicts in the literature, a system that blocks 
replication, without detrimental effects on the cell, would be useful. 
3.1.2 Why do mutations in TCA cycle enzyme, isocitrate 
dehydrogenase, confer resistance to low-levels of quinolones? 
For over three decades it has been know that mutations in icdA, which encodes 
for isocitrate dehydrogenase, lead to resistance to low-levels of the quinolone nalidixic 
acid, but the cause of this resistance has not been established [158]. The Helling lab 
hypothesized that these mutants accumulate an intermediate, such as citrate, which 
upregulates the AcrAB-TolC efflux pump, which then pumps out the intermediate along 
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with the antibiotic. They supported this hypothesis by showing evidence that the 
resistance seen in an icdA mutant is lost in the acrA icdA double mutant [159]. However, 
their conclusion was based on only a single data point, and another key data point was 
missing.  
The Collins lab's model for cell killing by three major classes of antibiotics, 
quinolones, -lactams, and aminoglycosides, is that these antibiotics stimulate the 
production of highly deleterious hydroxyl radicals. They hypothesized that the resistance 
in the icdA mutant is due to the depletion of NADH pools, which decreases levels of 
oxidative DNA damage [160]. This proposed model is a large shift from current models, 
and was the subject of a review published shortly after, pointing out several caveats 
[161]. More recent studies have provided strong experimental evidence against the 
Collins' model [162,163]. I revisited this issue by creating icdA mutants and acrA icdA 
double mutants, to test if knocking out the AcrA-TolC pump did indeed eliminate the 
quinolone resistance of an icdA mutant. 
3.2 Results 
3.2.1 Is replication necessary for the cytotoxicity of quinolones? 
The nucleotide analog and anti-HIV drug, Azidothymidine (AZT), acts as a chain 
terminator, because the azido group replaces the 3' OH of thymidine (Figure 12; 
reviewed in [164]). In E. coli, treatment with AZT quickly stops replication [134]. We 
performed experiments using the drug AZT to block replication, and determined if cell 
killing by the quinolone nalidixic acid was reduced. We learned that AZT is not a good 
tool for this test, because it also leads to extensive killing (approximately 20-fold in 1 
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hour; see Figure 13). AZT was also not an ideal system, because it leads to blocked 
replication forks on its own and it could be difficult to separate the effects of replication 
blockage and cell killing by quinolones to ensure that the cellular effects seen are due to 
the toxic effects of the quinolones. 
 
Figure 12: Structure of Azidothymidine (AZT) and thymidine 
AZT is a nucleotide analog with an azido group replacing the 3' OH of thymidine. 
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Figure 13:  Cells death induced by AZT treatment 
Wild-type strain JH39 was grown overnight, diluted 1:100 in LB and incubated for 
2 hours at 37 ̊ to reach OD560=0.5. The culture was then diluted to measure a pre-drug, 
time zero cell count (CFU/mL). The culture was split into two parts, receiving either AZT 
(0.25 µg/mL) or no drug and incubated for 60 minutes at 37̊. The culture was then diluted 
to measure a post-drug cell count (CFU/mL). N=3. Results were plotted on a log scale. 
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Use of a plasmid expressing coliphage N4 orf8 looked promising, because it was 
reported to shut off host DNA replication without killing the cells or inhibiting host 
transcription and translation [165]. Coliphage N4 orf8 inhibits DNA polymerase III 
holoenzyme in vitro, by targeting the clamp loader [165]. When we repeated an assay 
expressing this plasmid, in four different wild-type strains (MG1655, W3110, W3350 and 
BW25113), we were surprised to see approximately 500-fold killing, after only 20 
minutes of orf8 expression (Figure 14). We were unable to determine why, in our hands, 
cells are killed after orf8 is expressed, while the Rothman-Denes lab saw a bacteriostatic 
effect.  
We hoped that reducing expression of orf8 would inhibit replication without killing 
the cells. The orf8 pBad expression plasmid was therefore moved into the BW27783 
strain, for homogenous and titratable expression from the pBAD plasmid [143]. When 
the arabinose concentration was too low (1.25 x 10-5 %), cell growth was not inhibited 
completely, but compared to the no arabinose control, we see some inhibition (Figure 
15). When arabinose concentration was increased (2.5x10-4 % and 5.0 x 10-3 %), cells 
were killed approximately 30-fold (Figure 15). The killing may be due to the creation of 
blocked replication forks, which are processed into a toxic intermediate. In summary, 
neither AZT, nor orf8 expression, created an applicable system to test the requirement of 
DNA replication for the cytotoxicity of quinolones. Instead, we found that these two 
replication inhibitors induce substantial cell killing on their own. 
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Figure 14:  Cell death induced by expressing coliphage N4 orf8  
Wild-type strains MG1655, BW25113, W3110, and W3350 were grown overnight, 
diluted 1:100 in LB + 50 µg/mL amp and incubated 1.5 hours at 37 ̊ to reach OD560=0.3-
0.4. The culture was then diluted to measure a pre-sugar, time zero cell count (CFU/mL). 
The culture was split into two parts receiving either 0.2% arabinose or 0.2% glucose and 
incubated 20 minutes at 37 ̊. The culture was then diluted to measure a post-sugar cell 
count (CFU/mL).  
 
  
 
59
 
Figure 15:  Cell survival with Arabinose titration of orf8 expression in 
BW27783  
Wild-type strain BW27783 was grown overnight, diluted 1:100 in LB + 50 µg/mL 
amp and incubated 1.5 hours at 37 ̊ to reach OD560=0.3-0.4. The culture was then diluted 
to measure a pre-arabinose, time zero cell count (CFU/mL). The culture was split into 
two parts receiving varying arabinose concentrations (0%, 1.25 x 10-5 %, 2.5x10-4 %, and 
5.0 x 10-3 %) and incubated for 20 minutes at 37 ̊. The culture was then diluted to 
measure a post-arabinose cell count (CFU/mL).  
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3.2.2 Screen for Nalidixic acid bacteriostatic mutants 
As a strategy to elucidate the mechanism of cell killing by quinolones, I started a 
screen to find a transposon insertion mutant that is bacteriostatic in response to Nalidixic 
acid (nal). Finding a gene knockout that leads to a nal bacteriostatic phenotype could 
provide insight into the functions involved in killing by quinolones. Previous screens for 
nalidixic acid resistant mutants looked for mutants that could form colonies on nalidixic 
acid plates. I screened for mutants with increased survival after 1.5 hours of exposure to 
4 µg/mL nalidixic acid and created a collection of potential nalidixic acid bacteriostatic 
mutants. In a secondary screen, the wild-type control was killed about 25-fold while 
mutants were killed 4- to 10- fold. Unfortunately, P1 transductions showed that the 
transposon insertions were not responsible for the phenotype. We decided to suspend 
further work on this project due to that negative result.  
3.2.3 Why do mutations in TCA cycle enzyme, isocitrate 
dehydrogenase, confer resistance to low-levels of quinolones? 
Isocitrate dehydrogenase, icdA, mutants are moderately resistant to nalidixic acid 
[158] and the Helling lab hypothesized that these mutants accumulate an intermediate, 
such as citrate, which upregulates the AcrAB-TolC efflux pump, which then pumps out 
the intermediate along with the antibiotic. To test this hypothesis, they compared the 
growth in the presence of nalidixic acid for wild-type, icdA, acrA, and acrA icdA mutants 
[159]. However, their conclusion was based on only a single data point, and another key 
data point was missing. I revisited this issue by creating icdA, acrA, and acrA icdA 
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mutants, to test if knocking out the AcrA-TolC pump did indeed eliminate the quinolone 
resistance of an icdA mutant. Knocking out the AcrA-TolC pump makes the cells much 
more sensitive to nalidixic acid, so the data is presented on two graphs with the 
appropriate scale. We obtained the opposite result of the Helling lab, seeing that the 
protection in an icdA mutant background was still present when the AcrA-TolC pump 
was knocked out (Figure 16). We conclude that the Helling lab model does not hold up 
to contradict the Collins lab model. However, recent studies did provide strong 
experimental evidence against the Collins lab model [162,163]. We suspect the 
resistance of the icdA mutant and other TCA-cycle mutants, is likely due to a slow-
growth phenotype. 
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Figure 16:  Comparing quinolone resistance of an icdA mutant in wild-type 
and acrA strains 
MG1655 (wild-type) and indicated MG1655 derivatives were plated to nalidixic 
acid plates containing Nal at 0.25-1.5 µg/mL. Percent survival was calculated based on 
CFU on nal plates compared to no-drug control and plotted on a log scale. 
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3.2.4 Determination of the role of RecQ helicase in the response to 
quinolones 
A strategy our lab has used to learn more about the response to quinolones is to 
screen for mutants with a defect in inducing the SOS response in the presence of 
quinolones. We visualize the SOS response using the JH39 strain, which contains a 
dinD-lacZ fusion [166,167]. Upregulation of dinD, during the SOS response, can be seen 
as dark blue on X-gal plates or measured quantitatively by a β-galactosidase assay 
[168]. Newmark used the X-gal plate method, and performed a transposon mutagenesis 
screen to find mutants that are defective in inducing the SOS response in the presence 
of quinolones, but not in response to UV exposure [136]. Mutants with transposon 
insertions in recB and recC  were the only ones that fit the profile. Mutants with 
transposon insertions in 11 other genes were found to cause partial defects in SOS 
induction by one or both pathways. 
Mutants that express the SOS response in a partially constitutive manner would 
have likely been missed by Newmark's screen, as they are always dark blue on X-gal 
plates, due to constitutive expression of the dinD-lacZ reporter. O'Reilly created a 
collection of these SOS constitutive mutants [169] and tested their SOS profile in 
response to nalidixic acid and MMC, in the liquid, quantitative assay. Like UV, MMC 
induces SOS though the RecFOR pathway. A mutant with a transposon insertion in 
dnaQ, which encodes the epsilon subunit of DNA polymerase III, fit the profile of interest. 
The dnaQ knockout showed no increase in SOS induction in response to quinolones, but 
a normal response to MMC [170].  
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We suspected that a recQ mutant might also fit the profile of interest, with a 
defect in SOS induction in response to quinolones, because RecQ helicase was shown 
to be required for SOS induction after blockage of replication forks in a temperature-
sensitive dnaE mutant (polymerase III alpha subunit) [171]. I therefore created a recQ 
knockout and obtained evidence that recQ mutants are partially deficient in SOS 
induction by nalidixic acid using a quantitative β–Galactoside assay (Figure 17). An 
independent-samples, 2-tailed, t-test was conducted to compare the SOS response to 
nalidixic acid for wild-type and the ∆recQ mutant (comparing nal -  uninduced levels; 
Table 3). There was a significant difference in the average activity levels for wild-type 
(A=72.0, SD=22.2) and ∆recQ (A=50.2, SD=15.7); n=9, p = 0.029. Although the 
decrease was modest, these results suggest that the ∆recQ mutant does have a 
statistically significant decreased SOS response to nalidixic acid compared to wild-type.  
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Figure 17:  Miller's Assay of SOS induction in response to nalidixic acid in 
recQ double mutants 
β-Galactosidase assay was performed on JH39 (wild-type) and the indicated 
JH39 derivatives. SOS levels were measured in response to nal (10 µg/mL), MMC        
(1 µg/mL), and a no-drug control. JH39, recB, and recQ; n=9, double mutants; n=1.   
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Table 3: Induction of β-Galactosidase by nalidixic acid 
The data in this table are the measurements from Figure 17. n= number of 
colonies tested; ± is standard deviation; uninduced numbers are β-Galactosidase units 
expressed after 2 hours of growth in the absence of nal; + nal numbers are β-
Galactosidase units expressed after 2 hours of growth in the presence of nal; nal - 
uninduced if the difference between β-Galactosidase units in the presence of nal and 
those in the absence of nal; *p=0.029 is the p-value for the comparison of JH39 recQ nal 
- uninduced to JH39 nal – uninduced. 
 
Strain n uninduced + nal nal - uninduced 
JH39 9 6.9 ± 4.5 78.9 ± 20.7 72.0 ± 22.2 
JH39 recQ 9 7.6 ± 0.9 57.9 ± 15.9 50.2 ± 15.7  *p=0.029 
JH39 recB 9 4.9 ± 0.8 4.8 ± 0.6 -0.1 ± 0.6 
JH39 recQ ruvA 1 24.5 69.9 45.4 
JH39 recQ ruvC 1 22.6 71.8 49.2 
JH39 recQ uvrD 1 22.8 112.4 89.6 
JH39 recQ sbcC 1 14.3 81.2 66.9 
JH39 recQ intQ 1 12 85.1 73.1 
JH39 recQ mcrA 1 13.6 96.7 83.1 
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We were searching for a mutant with a complete loss of SOS induction in 
response to nalidixic acid, as seen in the recB mutant (Figure 17). The modest defect in 
the recQ mutant suggested redundant pathways, and so double mutants with a mutation 
in recQ and either recJ, helD, uvrD, ruvA, ruvC, sbcC, sbcD, intQ or mcrA were created 
and tested to see if the SOS response was completely lost. HelD and UvrD were chosen 
because they are also helicases, and could be performing a function similar to RecQ in 
response to quinolones. Exonuclease RecJ was chosen, because of its function with 
RecQ in the RecFOR pathway. Putative integrase IntQ and restriction endonuclease 
McrA were picked up in the Newmark screen as partially defective in the SOS response 
upon quinolone exposure [172]. RuvA and RuvC are subunits of the Resolvasome, and 
were candidates for involvement in the induction of the SOS response, because they 
can cleave replication forks in certain conditions [91]. SbcCD, a protein that has double-
strand DNA exonuclease activity as well as single-strand DNA endonuclease activity 
[111], was a candidate, because it has been shown to cleave palindromic branched DNA 
[112] as well as DNA near a tightly bound protein (streptavidin bound at biotin-tagged 
DNA end) [113]. 
None of the double mutants were defective in SOS induction as visualized by the 
dinD-lacZ reporter construct on X-gal plates (Figure 18). The very light blue rings seen 
with the recB mutant is the phenotype we hoped to obtain. Viewing color intensity on 
plates is not clear enough to pick up on gradual differences in SOS induction levels. The 
indicated mutants were tested using a quantitative liquid assay, to determine if they had 
a defect in SOS induction specifically to nalidixic acid, but not MMC. SOS constitutive 
mutants ruvA, ruvC and uvrD, required testing using a quantitative liquid assay, as they 
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are always dark-blue on the X-gal plates. Induction levels comparing nal exposure to 
lack of nal exposure were calculated (Table 3). Some of the double mutants have a 
greater response to nal (nal -  uninduced) than a recQ single mutant. This could be due 
to an increased sensitivity to nal. Also, double mutants were only tested one time and 
should be repeated at least two more times to look for reproducibility. Unfortunately, 
none of the double mutants showed a defect in SOS induction (Figure 17).  
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Figure 18:  Plate assay of SOS induction in response to nalidixic acid in 
recQ double mutants 
Overnight cultures of JH39 (wild-type) and the indicated JH39 derivatives were 
mixed with LB top agar and poured onto X-gal plates. 0, 10, 20, and 40 µg of nalidixic 
acid was pipetted onto the filter disk, starting in the top right corner, with concentrations 
increasing counter-clockwise. Plates were incubated at 37 overnight. The blue color 
indicates SOS induction, and the lack of color in the recB mutant indicates an inability to 
induce SOS. 
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 One potential model for RecQ helicase’s involvement in the response to 
quinolones is that it regresses a fork stalled at the site of the quinolone-stabilized 
cleavage complex. This regressed fork, which is also a Holliday junction, could be 
resolved into a double-strand break by RuvABC or processed with RecG branch 
migration, leading to cell death unless the break is repaired by RecBCD. I tested this 
model by creating a recQ recB double mutant. If the model was correct, we would have 
expected the double mutant to be less sensitive to the drug than the hypersensitive recB 
single mutant, because fork regression and break formation should be prevented. The 
recQ recB double mutants were just as sensitive as the recB single mutants, not 
supporting this model (Figure 19). The recQ single mutant displayed the same sensitivity 
as wild-type (Figure 19). 
  
 
71
 
Figure 19:  Growth kinetics for nalidixic acid sensitivity of recQ, recB, and 
recQ recB double mutant 
MG1655 (wild-type) and indicated MG1655 derivatives were tested for nal 
sensitivity using a microtiter plate sensitivity assay. Overnight cultures in LB media at 
37°C were diluted 1:200 in LB, and then mixed with an equal volume (75 µl each) of LB 
containing serial dilutions of nal for a final concentration ranging from 0.48 to 3.6 µg/ml in 
96-well plates. The cells were grown in the plate reader at 37°C with constant shaking, 
and OD630 was measured every 15 minutes for 12 h. Panel A are growth curves for the 
wild type and mutants. For the comparative titration curves in Panel B, a standardized 
point in the growth curve was first determined for each cell line, namely the time at which 
the growth rate of the no-drug culture dropped to 50% of the earlier exponential rate. 
The OD630 value at this time was then taken for each drug concentration and divided by 
the no-drug control to account for differences in growth rate.  
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3.2.5 Proteins that protect E. coli from quinolone antibiotics  
We tested twenty-five knockout mutants for quinolone (nalidixic acid and 
ciprofloxacin) sensitivity, extending multiple previous studies of quinolone sensitivities 
[106,107,173,174]. The collection of mutants was selected for TBC studies discussed in 
Chapter 2. Strains with mutations in recA, recB, recC, recG, uvrD, ruvA, ruvC, xseA, 
ftsK, and rep were found to be hypersensitive to exposure to quinolone antibiotics 
(Figure 21). Knockouts in most of these genes have previously been shown to cause 
quinolone hypersensitivity (see citations above), but two novel hypersensitive mutants 
emerged: rep and ftsK. The latter mutant would not have been identified in past studies 
(including [107]), because it is an essential gene and was not available as a complete 
gene knockout. As mentioned in Chapter 2, the transposon mutant used here is viable, 
because it contains the essential N-terminal 210 amino acids.  
We noted an interesting anomaly that should be considered whenever using the 
recF mutant from the Keio collection [144]. The deletion strain was noticeably resistant 
to quinolones, in contrast to recR or recO mutants, which behaved like wild type (Figure 
21). Inspection of the sequence of the deletion revealed that part of the promoter for the 
downstream gyrB gene is deleted, presumably leading to lower levels of DNA gyrase 
(and hence resistance to the poisoning effect of quinolones) (Figure 20). To gauge the 
effect of a simple loss of RecF function, we moved the null recF4115 point mutant [146] 
into this background, and found that the mutant displays wild-type sensitivity to 
quinolones (Figure 21).  
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Figure 20:  Polar effects on gyrB in ∆recF mutant 
The recF gene from start codon (3878171 bp) to stop codon (3879244 bp), is 
replaced by the Kanamycin resistance cassette (Tn5). The gyrB gene and transcription 
start site (3878173 bp) is intact, but the upstream -35 and -10 promoters and the binding 
sites of the transcriptional regulator, Fis, are removed in the Keio deletion. 
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Figure 21: Sensitivity to quinolone antibiotics 
Overnight cultures of BW27783 (wild-type) and the indicated BW27783 
derivatives were serial diluted five-fold and spotted onto LB plates containing either 
ciprofloxicin (5 or 7.5 ng/mL) or nalidixic acid (1.5 or 2.5 µg/mL) and incubated at 37 
overnight. Those mutants deemed to be hypersensitive are indicated with an asterisk. 
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3.3 Discussion 
I analyzed the quinolone sensitivity of twenty-five knockout mutants, the same 
mutant collection analyzed for sensitivity to TBCs (Chapter 2), for nalidixic acid and 
ciprofloxacin. This data allows us to compare survival to the various kinds of DNA-
protein complexes in a common genetic background and extend multiple previous 
studies of quinolone sensitivities [64,65,70,140]. A novel finding was that rep and ftsK 
mutants are hypersensitive to quinolones. Both Rep and FtsK have been shown to be 
capable of stripping proteins from DNA [57,115,124], an activity that could play some 
role in either resolving topoisomerase cleavage complexes and/or modulating blocked or 
broken replication forks. 
 We obtained some useful negative data, namely that mutations in recF, recO, 
recR, recJ, recQ, uvrA, sbcD, dinG, dnaJ, helD, hflC, mfd, polB and ssrA cause little or 
no hypersensitivity to quinolones (Figure 21). Every mutant that had been previously 
tested for quinolone sensitivity behaved essentially as expected. However, it should be 
noted that a strain lacking SbcCD was previously shown to be modestly hypersensitive 
to killing by nalidixic acid (but not ciprofloxacin), while the minimal inhibitory 
concentration was unaffected [175]. Also, in a spot test comparable to our approach, an 
SbcCD mutant was not hypersensitive to ciprofloxacin [107]. 
Attempts to test the necessity of on-going replication for the killing by quinolones 
were not successful. A difficulty in testing the effects of replication is finding an 
appropriate way to block replication without deleterious effects. Both the drug AZT and 
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the expression of coliphage N4 orf8 led to cell killing, making them unsuitable means of 
replication blocking for the study.  
We discovered that the Helling lab hypothesis of the reason for icdA mutants 
being resistant to low levels of quinolones was not correct. The resistance is not due to 
the accumulation of an intermediate such as citrate upregulating the AcrAB-TolC efflux 
pump, and then pumping out the intermediate along with the antibiotic [159]. Repeating 
their experiments, we saw that the resistance seen in an icdA mutant is not lost in an 
acrA icdA double mutant. Additional studies have supported the Collins lab model, that 
the loss of icdA and other TCA cycle genes, decreases NADH pools and has a 
downstream effect of decreasing the production of cytotoxic superoxide radicals 
sufficient (for review, see [176]). Recently, two studies provided strong experimental 
evidence against the Collins' model, by showing that the antibiotics did not lead to 
increased levels of hydrogen peroxide or elevate levels of free iron. Also, the lethality 
persisted in anaerobic conditions [162,163]. The resistance of the icdA mutant and other 
TCA-cycle mutants, is likely due to a slow-growth phenotype. 
 
In the continued pursuit of genetic mutants with interesting responses to 
quinolone exposure, we performed a screen for nalidixic acid bacteriostatic mutants. 
Unfortunately, the phenotype of the mutants collected was not due to the transposon 
insertion we created. More comprehensive analysis, like whole-genome sequencing, 
would be necessary to located the secondary mutations responsible for the phenotype. 
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We have yet to uncover another mutation that leads to an SOS profile like a 
recBC or a recQ mutant, with a failure to induce SOS in response to quinolones, but a 
regular response to UV or MMC. We did discover recQ mutants as partially defective in 
quinolone induction of SOS. Perhaps, the creation of more recQ double mutants would 
uncover a mutant with the phenotype of interest. The recB recQ growth kinetics in the 
presence of nalidixic acid did not support our hypothesis that RecQ helicase is 
regressing a fork stalled at the site of the quinolone-stabilized cleavage complex, which 
can be resolved into a DSB. We hypothesized that this DSB would lead to cell death 
unless the break is repaired by RecBCD, but the recQ mutation did not suppress the 
extreme hypersensitivity of the recBC mutant.  
3.4 Materials and Methods 
3.4.1 Materials 
LB (Luria broth) contained bacto tryptone (10 g/L), yeast extract (5 g/L), and 
sodium chloride (10 g/L). Kanamycin, nalidixic acid, ciprofloxacin and o-nitrophenyl-β-d-
galactopyranoside (ONPG) were purchased from Sigma. 5-bromo-4-chloro-3-indolyl-β-d-
galactopyranoside (X-Gal) was purchased from Gold Biotechnology, Inc.  
3.4.2 E. coli strains 
Strain JH39 [F- dinD1::Mu d(Apr lac) lac∆U169 srlD  sulA11  thr-1  leuB6(Am)  
hisG4(Oc)  argE3(Oc) ilv(ts) galK2(Oc) rpsL31], which has a dinD-lacZ fusion allowing 
for visualization of SOS induction on X-gal plates, was obtained from J. Heitman Lab 
(Duke University) [166,167]. The damage-inducible gene dinD is known to be 
upregulated during the SOS response, but the function of dinD is unknown. The level of 
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SOS induction in the JH39 strain, as measured by increased expression of the dinD-lacZ  
fusion, can be visualized on 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) 
reporter plates or by a liquid β-galactosidase assay [168]. The JH39 strain also has a 
mutation in sulA, which is a cell-cycle inhibitor induced during the SOS response. This 
mutation prevents filamentation and is necessary for the survival of many SOS 
constitutive mutants such as lexA [177,178]. 
Strain BW27783 [F-, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), λ-, ∆(araH-
araF)570(::FRT), ∆araEp-532::FRT, φPcp8araE535, rph-1, ∆(rhaD-rhaB)568, hsdR514)] 
allows for homogenous and titratable expression from pBAD vectors [143] and was 
obtained from the lab of HP Erickson (Duke University). Strain BW25113- [F-, λ-, 
∆(araD-araB)567, ∆lacZ4787(::rrnB-3), rph-1, ∆ (rhaD-rhaB)568, hsdR514] was 
obtained from Yale CGSC [179]. Strain MG1655- [F- λ- ilvG- rfb-50 rph-1] Strain W3110- 
[F- λ- rph-1 INV(rrnD, rrnE)] Strain W3350- [F- λ-  galK2(Oc) galT22 INV(rrnD-rrnE)] 
 E. coli knockout mutants from the Keio collection [144] contain kanamycin 
resistance gene inserts, and are identified as ∆ followed by gene name (e.g. ∆recA). In 
each case, the desired mutation was moved into the wild-type background via P1 
transduction [145], selecting for kanamycin resistance, and confirmed by PCR. The 
kanamycin-resistance cassette was not removed from the tested strains, with the 
exception of the recQ strain used to create the double mutants. The kanamycin-
resistance cassette is flanked by FRT sites allowing for removal by expressing Flp 
recombinase from plasmid pcp20 [180]. Successful removal was confirmed using PCR. 
The recF4115 missense mutant (K36Q) was moved into BW27783 using P1 
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transduction, selecting for a linked Tn10 marker (in tnaA; [146]); transductants were 
screened by DNA sequencing for co-transduction of the recF mutation.  
3.4.3 Growth kinetics for nalidixic acid sensitivity 
Nal sensitivity was measured with continuous growth curves in a temperature-
controlled ELx808™ Absorbance Microplate Reader. Overnight cultures in LB media at 
37°C were diluted 1:200 in LB, and then mixed with an equal volume (75 µl each) of LB 
containing serial dilutions of nal (0.48-3.6 µg/ml) in 96-well plates. The cells were grown 
in the plate reader at 37°C with constant shaking, and OD630 was measured every 15 
minutes for 12 h. 
3.4.4 Plate assay of SOS induction in response to nalidixic acid  
Overnight cultures of JH39 (wild-type) and the JH39 derivatives recB, recQ, and 
recQ double mutants were mixed with LB top agar (200 µL culture in 3 mL agar) and 
poured onto X-gal (90 μg/ml) plates. 0, 10, 20, and 40 µg of nalidixic acid was pipetted 
onto the filter disk and the plates were incubated at 37 overnight.  
3.4.5 Liquid assay of SOS induction in response to nalidixic acid  
Overnight cultures of JH39 (wild-type) and the JH39 derivatives recB, recQ, and 
recQ double mutants were diluted 100-fold and grown until they reached OD560=0.4. 
Each culture was divided into 3 tubes of 2 mL each for exposure to nal (10 µg/mL), MMC 
(1 µg/mL) or a no-drug control and grown for 2 hours. Cells were then pelleted in a 
microcentrifuge. β-Galactosidase assays were performed as described by Miller [145]. 
Cell pellets were resuspended in Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM 
KCl, 1 mM MgSO4, 10 mM dithiothreitol). 100 µL of chloroform and 50 µL drop of 0.1% 
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sodium dodecyl sulfate (SDS) were added to the cell suspension, which was then 
vortexed vigorously for 10 seconds. Appropriate amounts of the lysate were mixed with 
Z-buffer to a final volume of 1.0 ml. To start the reactions, 200 μl of o-nitrophenyl-β-d-
galactopyranoside (ONPG) (4 mM) was added, and the reaction mixtures were 
incubated at 30°C until a moderate yellow color was observed. The reactions were 
stopped with 0.5 ml of 1 M sodium bicarbonate, and the cellular debris was pelleted. The 
optical density was recorded with an ANTHOS 2001 plate reader with a 405-nm filter. 
Miller units were calculated as follows: units = 1,000[(OD405/(t × v × OD600)], where 
OD405 is the optical density at 405 nm of the reaction product, OD600 reflects the cell 
density at 600 nm, t is the reaction time in minutes, and v is the volume of culture used 
in the assay. 
3.4.6 Spot tests for sensitivity to quinolone antibiotics   
Overnight cultures of BW27783 (wild-type) and the indicated BW27783 
derivatives, containing plasmid pBAD-MEcoRII-C186A, were diluted to the equivalent of 
OD560 = 5x10-4 (corresponding to approximately 2 x 105 cells per mL). Five-fold serial 
dilutions were generated across a microtiter plate and 5 µl of each dilution (range of 
roughly 1,000-0.3 colony forming units for wild-type) was spotted onto LB plates 
containing chloramphenicol with either glucose (0.01%) or arabinose (0.0003%, 0.001%, 
0.003%, or 0.01%). The same dilutions were also spotted onto LB plates containing 
either ciprofloxicin (5 ng/mL or 7.5 ng/mL) or nalidixic acid (1.5 µg/mL or 2.5 µg/mL). All 
plates were incubated at 37 overnight. Spot tests were performed on each strain at 
least three times, and representative examples are shown. 
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3.4.7 Using AZT to block replication   
Wild-type strain JH39 was grown overnight, diluted 1:100 in LB and incubated for 
2 hours at 37 ̊ to reach OD560=0.5. The culture was then diluted to measure a pre-drug 
cell count (CFU/mL). The culture was split into two parts, receiving either AZT (0.25 
µg/mL) or no drug and incubated 60 minutes at 37 ̊. The culture was then diluted to a 
range of 1:10-1:10,000 and pipetted onto LB plates to measure a post-drug cell count 
(CFU/mL) and calculate the percentage killed. 
3.4.8 Expressing coliphage N4 orf8 to block replication 
Wild-type strains MG1655, W3110, W3350 and BW25113, were grown overnight, 
diluted 1:100 in LB + 50 µg/mL amp and incubated 1.5 hours at 37 ̊ to reach OD560=0.3-
0.4. The culture was then diluted to measure a pre-sugar cell count (CFU/mL). The 
culture was split into two parts receiving either 0.2% arabinose or 0.2% glucose and 
incubated 20 minutes at 37 ̊. The culture was then diluted to a range of 1:10-1:10,000 
and pipetted onto LB plates to measure a post-sugar cell count (CFU/mL) and calculate 
the percentage killed. The same protocol was followed for BW27783 wild-type, with the 
adjustment of arabinose concentrations of 1.25 x 10-5 %, 2.5x10-4 %, and 5.0 x 10-3 % 
used instead of 2%. 
3.4.9 Comparing quinolone resistance of an ∆icdA mutant in wild-type 
and ∆acrA strains  
MG1655 (wild-type) and indicated Keio collection knockouts were grown 
overnight and diluted to plate approximately 1x108 cells onto nalidixic acid plates 
containing nal at 0.25, 0.375, 0.5, 0.625, 0.75, 0.875, 1 or 1.5 µg/mL and a no-drug 
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control. Percent survival was calculated based on CFU on nal plates compared to no-
drug control and plotted on a log scale. 
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Chapter 4:  Discussion and Future Directions 
4.1 Summary of results 
In this study, we analyzed the in vivo consequences and protein requirements for 
survival upon expression of the tight-binding mutant M.EcoRII protein (C186A), which 
creates solo TBCs. As discussed in Chapter 1 and 2, the mechanisms behind the 
lethality induced by solo TBCs have not been well studied, nor is it clear whether very 
tight binding but noncovalent complexes are processed in the same way as covalent 
DPCs. Using the same 2D gel electrophoresis technique performed on aza-C-induced 
DPCs [43], we visualized that an M.EcoRII-C186A-induced TBC could also block 
replication forks in vivo (Figure 5). A difference in the 2D gel patterns is that the aza-C-
induced DPCs caused an accumulation of X structures and a prominent Y-arc [43]. The 
X structures were not present in a recA mutant and are likely created by RecA-
dependent recombination or replication fork regression. Electron microscopy was used 
to determine that aza-C-induced DPCs were causing rolling-circle replication, leading to 
the prominent Y-arc [43]. Normal theta replication can be converted to rolling-circle 
replication if the blocked fork is cleaved.  
We also performed an extensive candidate gene screen for mutants that are 
hypersensitive to the M.EcoRII-induced solo TBCs. A powerful aspect of this system is 
that previous studies, from our lab and others, have already identified a variety of 
mutants that are hypersensitive to aza-C-induced DPCs that involve the same M.EcoRII 
protein (except that the DPCs utilize the wild-type version of the protein) 
[28,43,45,46,47,48,49] (reviewed in [42]; Krasich et al., unpublished data). We now have 
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a direct comparison of cellular functions that protect against the same tightly bound 
protein in either non-covalent or covalent form (summarized in Table 4). Several gene 
products are needed for protection against both kinds of complexes, including RecA, 
RecBC, RecG, RuvABC, UvrD, FtsK, and SsrA (tmRNA). The recombination proteins 
likely function in processing blocked replication forks or downstream DNA breaks 
resulting from blocked forks, given that both kinds of M.EcoRII complex block replication 
forks ([43]; Figure 5). Involvement of the tmRNA pathway indicates that both kinds of 
complex also block the coupled transcription-translation machinery (see [49]).  
Interestingly, different but overlapping functions are involved in surviving TBCs 
versus DPCs, both involving the M.EcoRII protein. The most striking difference between 
the responses to the TBCs versus DPCs is that the RecFOR pathway is important in the 
response to TBCs induced by M.EcoRII-C186A but not to DPCs induced by aza-C with 
the wild-type protein. The RecFOR pathway is possibly involved in protecting the 
replication fork stalled at the TBC from degradation. Rep helicase is another function 
that is involved in the response to TBCs, but not DPCs. Rep could be involved in 
dissociating the tightly-bound protein from the DNA. Our model for the repair of 
M.EcoRII-C186A-induced TBCs is that RecFOR along with RecA stabilize the stalled 
fork, allowing Rep to remove the TBC. The tmRNA system could help overcome the 
TBC-mediated blockage of coupled transcription-translation complexes. 
In addition to the ability to compare aza-C-induced DPCs involving wild-type M. 
EcoRII, with M.EcoRII-C186A induced TBCs, formed at the same M.EcoRII DNA 
recognition sequence, we also have data for the same mutants in response to 
quinolone-induced DPCs (summarized in Table 4). RecA, RecBC, RecG, and RuvABC 
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are involved in protection from M.EcoRII-C186A induced TBCs, quinolones, and aza-C-
induced DPCs, and due to their roles in replication and repair, this is not a surprising 
finding. The involvement of these proteins implies that DSBs are formed, as RecBCD is 
required for processing DSBs to allow for RecA-mediated HR. The recombination 
reaction yields a Holliday junction, which can be resolved by either the RuvABC 
resolvasome or branch migration by RecG helicase [25,26,27]. The result of FtsK being 
hypersensitive to all three is very interesting. Hypersensitivity could be attributed to a 
role in chromosome segregation after damage or a role in stripping proteins off DNA 
([57,115,124]; see below for more discussion). Another novel finding is that in addition to 
being hypersensitive to M.EcoRII-C186A-induced TBCs, rep mutants are also 
hypersensitive to quinolones. Like FtsK, Rep is also capable stripping proteins from DNA 
[57,115,124], and could have a role in either resolving topoisomerase cleavage 
complexes or processing broken replication forks. 
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Table 4:  Sensitivity to M.EcoRII-C186A-induced TBCs, quinolones, and 
aza-C-induced DPCs 
This table summarizes the sensitivity of various E. coli mutants to TBCs induced 
by M.EcoRII (Figure 6; this study), topoisomerase cleavage complexes (Figure 21; this 
study; also see citations in the text to past studies of quinolone-sensitive mutants), and 
DPCs induced by wild-type M.EcoRII proteins with aza-C treatment (indicated citations; 
[#] refers to Krasich, Wu, Kuo and Kreuzer, unpublished data). 
 
 TBCs (Figure 6) 
Quinolones 
(Figure 21) M.EcoRII DPCs (aza-C-induced)  
dinG wild-type wild-type hypersensitive [#] 
dnaJ wild-type wild-type hypersensitive [49]  
ftsK  hypersensitive hypersensitive  hypersensitive [#]  
helD wild-type wild-type not reported 
hflC  wild-type wild-type hypersensitive [49]  
mfd  wild-type wild-type wild-type [48,49] 
polB wild-type wild-type wild-type [48] 
recA hypersensitive hypersensitive hypersensitive [45,46,47,48] [#] 
recBC hypersensitive hypersensitive hypersensitive [48] [#]  
recFOR hypersensitive wild-type wild-type [47] [#]  
recG hypersensitive hypersensitive hypersensitive [48] [#]  
recJ wild-type wild-type wild-type [48] 
recQ wild-type wild-type wild-type [48] 
rep hypersensitive hypersensitive  wild-type [#]  
ruvABC hypersensitive hypersensitive hypersensitive [48] [#]  
sbcCD wild-type wild-type wild-type [#]  
ssrA hypersensitive wild-type hypersensitive [49]  
uvrA wild-type wild-type wild-type [45,46,47,48,49] 
uvrD hypersensitive hypersensitive hypersensitive [48,49] 
xseA wild-type hypersensitive not reported 
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4.2 Characterization of hypersensitive mutants and creation of 
additional mutants 
4.2.1 Visualizing replication intermediates to test models for RecFOR,  
Rep, and UvrD involvement in the processing of M.EcoRII-C186A 
induced TBCs 
Both aza-C-induced DPCs [43] and M.EcoRII-C186A-induced TBCs block 
replication forks in vivo (Figure 5), as seen by an accumulation of bubble molecules on a 
2D gel. Only the DPCs led to Y forms and RecA-dependent X structures, which indicates 
that DPCs lead to more frequent fork breakage than TBCs (Figure 5; [43]; see Chapter 2 
discussion). The X structures are likely due to RecBCD-RecA mediated HR or replication 
fork regression. The ability of the RecFOR pathway to stabilize the forks stalled by TBCs 
may minimize fork breakage and permit Rep to dissociate the TBC. A future project 
would be to run 2D gels for the M.EcoRII-C186A hypersensitive mutants. It would be of 
particular interest to see if ∆recFOR, ∆rep, and ∆uvrD mutants have an accumulation of 
Y forms and X structures, due to more fork breakage. Seeing an increase in broken forks 
in ∆recFOR and ∆rep, but not ∆uvrD mutants would support the hypothesis that RecFOR 
and RecA stabilize forks stalled by TBCs, promoting the release of TBC by Rep. While 
UvrD can remove transcription factors from arrays (as well as Tus and RecA), we 
speculate it is not powerful enough to remove a very tight binding M.EcoRII-C186A. We 
would also expect a decrease in the spots on the bubble arc, in ∆recFOR mutants, 
corresponding to a decrease in stabilized blocked forks. Conversely, we would expect an 
increase in intensity of spots on the bubble arc in a ∆rep mutant when Rep is not 
clearing TBCs due to less (or more transient) fork blockage. 
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4.2.2 Models for FtsK involvement in processing DNA-Protein 
complexes 
As mentioned above, we obtained the interesting result that ftsK mutants are 
hypersensitive to M.EcoRII-C186A induced TBCs (Figure 6) and quinolones (Figure 21) 
while other work also showed ftsK sensitivity to aza-C-induced DPCs (Krasich, 
unpublished data). FtsK is capable of stripping proteins off DNA in vitro, including the 
removal of MatP bound to matS [124]. MatP binds matS in the ter region to prevent early 
segregation of that domain during cell division [181]. FtsK can also displace streptavidin 
from biotin on DNA (Graham,J.E., Sherratt,D.J., Crozat,E. and Howarth,M. unpublished 
data cited in [181]). Also, the Bacillus subtilis FtsK orthologue, SpoIIIE, is capable of 
stripping proteins from DNA during spore formation [182]. This supports a model where 
FtsK has a function in removing the tightly-bound M.EcoRII-C186A protein.  
Future work with FtsK can test the hypothesis that is has a function in removing 
DNA-Protein complexes in vivo. A future experiment would be to perform 2D gels, as 
detailed in Chapter 2, and see if ftsK mutants have an increase in blocked forks, as seen 
by spots on the bubble arc. This would support the model that FtsK is removing the TBC.  
The triplex displacement assay used to show that FtsK can remove MatP bound 
to matS [124] could be used to test if FtsK can remove M.EcoRII-C186A-induced TBCs 
in vitro. To perform this assay, a DNA substrate would be engineered containing a triplex 
binding site downstream of an M.EcoRII recognition site. The substrate would be 
incubated with M.EcoRII-C186A and radio-labeled Triplex DNA. The displacement of 
Triplex DNA can be measured using gel electrophoresis. The percentage of M.EcoRII-
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C186A displaced by FtsK can be calculated based on the amount of Triplex DNA 
displaced. The same test could be used for aza-C-induced DPCs. 
Alternatively, hypersensitivity could reflect some important role in segregation of 
chromosomes after damage, for example assisting XerCD in chromosome dimer 
resolution following HR induced by DPCs or TBCs. XerCD is a site-specific recombinase 
that resolves chromosome dimers [183]. The DSBs created by the DPCs, TBCs, and 
quinolones presumably require RecBCD-RecA mediated HR. Depending on how the 
resulting Holliday junction is resolved, such chromosomal HR can yield two linked copies 
of the chromosome, which need to be resolved prior to cell division. FtsK assisting 
XerCD may be required for chromosome dimer resolution before cell division can take 
place. Mutants of xerC and xerD would be of interest to test for hypersensitivity to aza-C, 
quinolones, and M.EcoRII-C186A-induction. This model would be supported if they are 
also hypersensitive. 
4.2.3 Does the primosome have a role in replication fork restart 
following M.EcoRII-C186A induced TBCs?  
PriA and PriB are components for the primosome, which is a complex involved in 
replication fork restart and the replication of certain phages and plasmids. When forks 
are blocked at UV damage, PriAB and Rep are required to stabilize the replisome to 
resume DNA synthesis [90]. It would be of interest to test if priA and priB mutants are 
hypersensitive to M.EcoRII-induced TBCs. 
Mutants of priA have reduced viability and are therefore more difficult to work 
with. It is important to continuously confirm that additional suppressor mutations have 
not been acquired. I created a priA mutant, but was unable to transform in plasmid 
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pBAD-MEcoRII-C186A. A functional PriA is required for replication of the pBR322 
plasmid [184] and the lack of PriA was potentially the cause of the inability to obtain priA 
pBAD-MEcoRII-C186A transformants. A future direction is to instead create a BW27783 
∆priB pBAD-MEcoRII-C186A strain and test its sensitivity to M.EcoRII-induced TBCs. 
4.2.4 Model for RuvABC and SbcCD involvement at TBC-blocked 
forks 
RuvA and RuvC are subunits of the Resolvasome, which resolves Holliday 
junctions and contributes to rescue of blocked DNA replication forks through replication 
fork reversal [52,69]. RuvA and RuvC knockout mutants are hypersensitive to aza-C-
induced DPCs ([48]; Krasich et al, unpublished data), quinolone-induced cleavage 
complexes [65,70] and TBCs induced by M.EcoRII-C186A (Figure 6). We propose a 
model that M.EcoRII-C186A-induced TBC-blocked replication forks are sometimes 
cleaved by a nuclease to generate broken forks, which need to be repaired by RecBCD- 
and RuvABC-dependent HR. Evidence to support this model is that recBC mutants are 
hypersensitive to M.EcoRII-C186A-induced TBCs and that these TBCs lead to blocked 
replication forks (see Chapter 2). We presume that a nuclease other than RuvABC is 
responsible for the fork cleavage as ruvA and ruvC mutants are hypersensitive to the 
induction of these TBCs.  
One candidate for a nuclease that might cleave the blocked forks, or even DNA 
near the tightly bound protein, is SbcCD. This protein has double-strand DNA 
exonuclease activity as well as single-strand DNA endonuclease activity [111], and has 
been shown to cleave forks and tightly-bound proteins (see Chapter 2). We found that 
sbcD mutants are not hypersensitive to TBCs induced by M.EcoRII-C186A (Figure 6). If 
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SbcCD is cleaving TBC blocked forks, the broken fork could lead to cell death unless 
repaired by RecBCD. To test this model, we would create a sbcD recB double mutant. If 
the model was correct, we would expected the double mutant to be less sensitive to 
M.EcoRII-C186A induced TBCs than the hypersensitive recB single mutant, because 
break formation should be prevented. The same test would be performed with a sbcD 
ruvC double mutant to see if results support an involvement of RuvABC-dependent HR 
in the repair. 
4.2.5 Is the tmRNA system induced when RNA polymerase is blocked 
by TBCs? 
SsrA (tmRNA) releases stalled ribosomes from the end of an mRNA lacking a 
stop codon. Mutants of ssrA are sensitive to both aza-C-induced DPCs [49] and 
M.EcoRII-induced TBCs (Figure 6). This result argues that the tmRNA system plays an 
important role in clearing stalled ribosome-mRNA complexes generated after 
transcription is blocked by  both aza-C-induced DPCs and M.EcoRII-induced TBCs. We 
therefore propose that M.EcoRII-C186A, bound to its recognition sites, can block RNA 
polymerase and the coupled translation machinery in much the same way as covalently 
attached M.EcoRII.  
To demonstrate that the tmRNA system is involved in surviving aza-C-induced 
DPCs, aza-C treated cells expressing wild-type M.EcoRII were tested for an increase in 
SsrA tagged proteins [49]. Performing Western blotting with an antibody against the wild-
type SsrA tag, it was shown that aza-C treatment led to a substantial increase in SsrA-
tagged proteins in wild-type cells expressing M.EcoRII. The same Western blotting could 
be performed to determine if M.EcoRII-C186A-induced TBCs also lead to an increase in 
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SsrA-tagged proteins. We would expect a loss of tagging in the ssrA mutant. UvrD and 
Rep could play a role in removing the coupled transcription-translation machineries 
blocked by the TBC. Hypersensitive mutants, uvrD and rep, would also be tested for an 
increase in SsrA tagging which would support this hypothesis.  
4.3 Sensitivity to quinolone-induced DPCs   
In addition to the novel finding that rep and ftsK mutants are hypersensitive to 
quinolones (discussed above), we uncovered a few additional mutant phenotypes with 
quinolone studies. We discovered that recQ mutants are partially defective in quinolone 
induction of SOS. However, we did not obtain a double mutant completely defective in 
quinolone induction of SOS. Double mutants of recQ rep and recQ ftsK would be of 
interested to test for SOS response, due to the quinolone hypersensitivity.  
We determined that the modest quinolone resistance seen in an icdA mutant is 
not lost in an acrA icdA double mutant, invalidating the Helling lab hypothesis that of the 
reason for icdA mutants being resistant to low levels of quinolones is due to upregulation 
of AcrAB-TolC efflux pump. Two recent studies did provide strong experimental 
evidence against the Collins lab model that the modest resistance of an icdA mutant was 
due to depletion of NADH pools and therefore a decrease in ROS ([162,163]; see 
Chapter 4 discussion). We suspect the resistance of the icdA mutant is likely due to a 
slow-growth phenotype. This hypothesis could be tested by measuring the nal resistance 
of other slow-growing mutants. Measurements of resistance due to growth rate can also 
be performed by comparing nal resistance in rich media to minimal media and growth at 
37°C to 30°C. 
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4.4 Final remarks   
This work expands on the knowledge of how cells tolerate and process TBCs 
and blocked replication forks. It also allows for a direct comparison to DPCs between the 
same protein and DNA sequence, as well as DPCs created by quinolone treatment. The 
M.EcoRII-C186A system has many advantages over existing methods to study TBCs 
and continued work utilizing this system should prove to be very valuable in the field. 
Further characterization of the TBC hypersensitive mutants as well as the creation of 
new mutants, will also greatly expand on our understanding of the mechanisms behind 
TBC-induced DNA damage. 
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